-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ARathz3hCYABOenxflR7ib4o9jUX6E2/FrcLOGDKPPDFh0qaBSdbtu6uSNmu6NTb L4InLu42NBin/7VTVjdPuQ== 0000912057-02-014921.txt : 20020416 0000912057-02-014921.hdr.sgml : 20020416 ACCESSION NUMBER: 0000912057-02-014921 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20020412 GROUP MEMBERS: ASSOCIATED MADISON COMPANIES,INC. GROUP MEMBERS: PFS SERVICES,INC. GROUP MEMBERS: THE TRAVELERS INDEMNITY COMPANY GROUP MEMBERS: THE TRAVELERS INSURANCE COMPANY GROUP MEMBERS: TRAVELERS INSURANCE GROUP HOLDINGS,INC. GROUP MEMBERS: TRAVELERS PROPERTY CASUALTY CORP. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ON2 TECHNOLOGIES INC CENTRAL INDEX KEY: 0001045280 STANDARD INDUSTRIAL CLASSIFICATION: MORTGAGE BANKERS & LOAN CORRESPONDENTS [6162] IRS NUMBER: 841280679 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-56347 FILM NUMBER: 02609811 BUSINESS ADDRESS: STREET 1: 145 HUDSON STREET CITY: NEW YORK STATE: NY ZIP: 10013 BUSINESS PHONE: 9172370500 MAIL ADDRESS: STREET 1: 645 FIFTH AVE STREET 2: C/O STEVEN SISKIND CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: ON2COM INC DATE OF NAME CHANGE: 19990622 FORMER COMPANY: FORMER CONFORMED NAME: APPLIED CAPITAL FUNDING INC DATE OF NAME CHANGE: 19971002 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CITIGROUP INC CENTRAL INDEX KEY: 0000831001 STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021] IRS NUMBER: 521568099 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 399 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10043 BUSINESS PHONE: 2125591000 MAIL ADDRESS: STREET 1: 399 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10043 FORMER COMPANY: FORMER CONFORMED NAME: TRAVELERS INC DATE OF NAME CHANGE: 19940103 FORMER COMPANY: FORMER CONFORMED NAME: TRAVELERS GROUP INC DATE OF NAME CHANGE: 19950519 FORMER COMPANY: FORMER CONFORMED NAME: PRIMERICA CORP /NEW/ DATE OF NAME CHANGE: 19920703 SC 13D/A 1 a2076677zsc13da.txt SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* On2 Technologies, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $0.01 - -------------------------------------------------------------------------------- (Title of Class of Securities) 68338A-10-7 - -------------------------------------------------------------------------------- (CUSIP Number) Joseph B. Wollard, Esq. Citigroup Inc. 425 Park Avenue New York, NY 10043 (212) 559-1000 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 27, 2002 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss.240.13d-7 for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). - ---------------------------- ------------------------- CUSIP No. 68338A-10-7 SCHEDULE 13D - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) The Travelers Insurance Company ("TIC") - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) X (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* WC - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Connecticut - -------------------------------------------------------------------------------- NUMBER OF SHARES 7 SOLE VOTING POWER 0 ----------------------------------------------------- BENEFICIALLY OWNED BY 8 SHARED VOTING POWER 10,958,572** ----------------------------------------------------- EACH REPORTING PERSON 9 SOLE DISPOSITIVE POWER 0 ----------------------------------------------------- WITH 10 SHARED DISPOSITIVE POWER 10,958,572** - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 10,958,572** - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 20.5%** - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* IC - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! **Represents (1) 1,600,000 shares of Common Stock directly beneficially owned by TIC, (2) 400,000 shares of Common Stock indirectly beneficially owned by TIC through ownership of 400,000 Preferred Stock Purchase Units ("Company Units") issued by On2 Technologies, Inc. (the "Company"), (3) options to purchase 30,000 shares of Common Stock, (4) 3,571,429 shares of the Company's Series C-VI Preferred Stock, no par value ("Series C-VI Preferred") and (5) 5,357,143 warrants ("Series C-VI Warrants"). Each Company Unit consists of one share of no par value Series A Convertible Preferred Stock ("Series A Preferred"). Each share of Series A Preferred is non-voting and may be converted at the Reporting Person's option, at any time, into one share of the Company's Common Stock. Each share of Series C-VI Preferred is non-voting and may be converted into one share of Common Stock, subject to certain terms and conditions. Each Series C-VI Warrant may be exchanged for one share of Common Stock at an exercise price of $0.56 per share, subject to certain terms and conditions. - ----------------------------- ------------------------------ CUSIP No. 68338A-10-7 SCHEDULE 13D - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) The Travelers Indemnity Company ("Travelers Indemnity") - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) X (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* WC - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Connecticut - -------------------------------------------------------------------------------- NUMBER OF SHARES 7 SOLE VOTING POWER 0 ----------------------------------------------------- BENEFICIALLY OWNED BY 8 SHARED VOTING POWER 12,682,295** ----------------------------------------------------- EACH REPORTING PERSON 9 SOLE DISPOSITIVE POWER 0 ----------------------------------------------------- WITH 10 SHARED DISPOSITIVE POWER 12,682,295** - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 12,682,295** - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 23.9%** - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* IC - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! ** Represents (1) 2,934,592 shares of Common Stock directly beneficially owned by Travelers Indemnity, (2) 2,578,947 shares of the Company's Series C-IV Preferred Stock, par value of $0.01 per share ("Series C-IV Preferred"), (3) 644,741 Series C-IV Warrants ("Series C-IV Warrants"), (4) 5,227,552 shares of the Company's Series C-V Preferred Stock, par value of $0.01 per share ("Series C-V Preferred"), and (5) 1,296,463 Series C-V Warrants ("Series C-V Warrants"). Each share of Series C-IV and C-V Preferred is non-voting and may be converted into one share of Common Stock, subject to certain terms and conditions. Each Series C-IV and C-V Warrant may be exchanged for one share of Common Stock, subject to certain terms and conditions. - ----------------------------- ---------------------------- CUSIP No. 68338A-10-7 SCHEDULE 13D - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Travelers Insurance Group Holdings Inc. (f/k/a Travelers Property Casualty Corp.) - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) X (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* AF - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF SHARES 7 SOLE VOTING POWER 0 ----------------------------------------------------- BENEFICIALLY OWNED BY 8 SHARED VOTING POWER 12,682,295** ----------------------------------------------------- EACH REPORTING PERSON 9 SOLE DISPOSITIVE POWER 0 ----------------------------------------------------- WITH 10 SHARED DISPOSITIVE POWER 12,682,295** - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 12,682,295** - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 23.9%** - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* HC - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! ** Represents shares beneficially owned by Travelers Indemnity. - ------------------------------ ---------------------------- CUSIP No. 68338A-10-7 SCHEDULE 13D - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Travelers Property Casualty Corp. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) X (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* AF - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Connecticut - -------------------------------------------------------------------------------- NUMBER OF SHARES 7 SOLE VOTING POWER 0 ----------------------------------------------------- BENEFICIALLY OWNED BY 8 SHARED VOTING POWER 12,682,295** ----------------------------------------------------- EACH REPORTING PERSON 9 SOLE DISPOSITIVE POWER 0 ----------------------------------------------------- WITH 10 SHARED DISPOSITIVE POWER 12,682,295** - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 12,682,295** - ------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 23.9%** - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* HC - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! ** Represents shares beneficially owned by Travelers Indemnity. - ------------------------------- ------------------------- CUSIP No. 68338A-10-7 SCHEDULE 13D - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) PFS Services, Inc. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) X (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* AF - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Georgia - -------------------------------------------------------------------------------- NUMBER OF SHARES 7 SOLE VOTING POWER 0 ----------------------------------------------------- BENEFICIALLY OWNED BY 8 SHARED VOTING POWER 23,640,867** ----------------------------------------------------- EACH REPORTING PERSON 9 SOLE DISPOSITIVE POWER 0 ----------------------------------------------------- WITH 10 SHARED DISPOSITIVE POWER 23,640,867** - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 23,640,867** - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 37.8%** - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* HC - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! ** Represents shares beneficially owned by Travelers Indemnity and TIC. - --------------------------- ------------------------- CUSIP No. 68338A-10-7 SCHEDULE 13D - ------------- ------------------------------------------------------------------ 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Associated Madison Companies, Inc. - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) X (b) |_| - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* AF - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF SHARES 7 SOLE VOTING POWER 0 ----------------------------------------------------- BENEFICIALLY OWNED BY 8 SHARED VOTING POWER 23,640,867** ----------------------------------------------------- EACH REPORTING PERSON 9 SOLE DISPOSITIVE POWER 0 ----------------------------------------------------- WITH 10 SHARED DISPOSITIVE POWER 23,640,867** - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 23,640,867** - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 37.8%** - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* HC - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! ** Represents shares beneficially owned by Travelers Indemnity and TIC. - -------------------------- ------------------------------ CUSIP No. 68338A-10-7 SCHEDULE 13D - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Citigroup Inc. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) X (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* AF - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF SHARES 7 SOLE VOTING POWER 0 ----------------------------------------------------- BENEFICIALLY OWNED BY 8 SHARED VOTING POWER 23,653,027** ----------------------------------------------------- EACH REPORTING PERSON 9 SOLE DISPOSITIVE POWER 0 ----------------------------------------------------- WITH 10 SHARED DISPOSITIVE POWER 23,653,027** - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 23,653,027** - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 37.8%** - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* HC - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! ** Represents shares beneficially owned by Travelers Indemnity, TIC and other subsidiaries of Citigroup Inc. SCHEDULE 13D ITEM 1. SECURITY AND ISSUER This Amendment No. 4, to a Schedule 13D filed on May 17, 2000, as amended by Amendment No. 1 filed on June 16, 2000, Amendment No. 2 filed on July 23, 2001, and Amendment No. 3 filed on August 17, 2001, relates to the Common Stock, par value $0.01, of On2 Technologies, Inc., formerly known as On2.com, Inc. (the "Company"), a Delaware corporation. Information contained in the original Schedule 13D remains in effect except to the extent that it is superseded by subsequently filed information, including the information contained in this Amendment No. 4. Information given in response to each item shall be deemed incorporated by reference in all other items. Terms used and not defined herein have the meaning ascribed to them in said Schedule 13D. ITEM 2. IDENTITY AND BACKGROUND. The response to Item 2 of the Schedule 13D is hereby amended and supplemented as follows: (a) This Schedule 13D is being filed by (i) The Travelers Insurance Company, a Connecticut corporation ("TIC"), by virtue of its beneficial ownership of the Company's Common Stock (including securities that may be converted into Common Stock), (ii) The Travelers Indemnity Company, a Connecticut corporation ("Travelers Indemnity"), by virtue of its beneficial ownership of the Company's Common Stock (including securities that may be converted into Common Stock), (iii) Travelers Insurance Group Holdings Inc. (formerly known as Travelers Property Casualty Corp.), a Delaware corporation ("TIGHI"), by virtue of its ownership of all of the outstanding common stock of Travelers Indemnity, (iv) Travelers Property Casualty Corp., a Connecticut corporation ("TAP"), by virtue of its ownership of all of the outstanding common stock of TIGHI, (v) PFS Services, Inc., a Georgia corporation ("PFS"), by virtue of its ownership of all of the outstanding common stock of TIC and 77% of the outstanding equity of TAP, (vi) Associated Madison Companies, Inc., a Delaware corporation ("Associated Madison"), by virtue of its ownership of all of the outstanding common stock of PFS, and (vii) Citigroup Inc., a Delaware corporation ("Citigroup"), by virtue of its ownership of all the outstanding common stock of Associated Madison (collectively, the "Reporting Persons," and each a "Reporting Person"). Attached as Schedule A is information concerning each executive officer and director of TIC, Travelers Indemnity and Citigroup. Schedule A is incorporated into and made a part of this Schedule 13D. (b) The address of the principal business and principal place of business of each of TIC, Travelers Indemnity, TIGHI and TAP is One Tower Square, Hartford, Connecticut 06183. The address and principal place of business of PFS is 3120 Breckinridge Boulevard, Duluth, Georgia 30199. The address and principal place of business of each of Associated Madison and Citigroup is 399 Park Avenue, New York, New York 10043. (c) TIC's principal business is life insurance. Travelers Indemnity's principal business is property and casualty insurance. TIGHI and TAP are holding companies principally engaged, through their subsidiaries, in property and casualty insurance. PFS and Associated Madison are holding companies principally engaged, through their subsidiaries, in insurance and related financial services. Citigroup is a diversified holding company providing, through its subsidiaries, a broad range of financial services to consumer and corporate customers world-wide. (d) During the last five years, none of the Reporting Persons, nor, to the knowledge of each Reporting Person, any of their respective officers, directors or controlling persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) During the last five years, none of the Reporting Persons, nor, to the knowledge of each Reporting Person, any of their respective officers, directors or controlling persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f) Each of TIC and Travelers Indemnity is a Connecticut corporation. PFS is a Georgia corporation. Each of TIGHI, TIC, Associated Madison and Citigroup is a Delaware corporation. Except as otherwise indicated on Schedule A, to the knowledge of each Reporting Person, each executive officer and director named in Schedule A to this Schedule 13D are citizens of the United States. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. The response to Item 3 of the Schedule 13D is hereby amended and supplemented as follows: As consideration for the transaction described in Item 4 of this Schedule 13D, Travelers Indemnity surrendered to the Company 1,644,304 shares of Series C Preferred Stock and Series C Warrants to purchase 411,076 shares of Common Stock. ITEM 4. PURPOSE OF TRANSACTION. The response to Item 4 of the Schedule 13D is hereby amended and supplemented as follows: Travelers Indemnity and the Company entered into a Deferred Pricing Agreement (the "Pricing Agreement") dated as of January 18, 2001, a copy of which is attached as Exhibit 2 and which is incorporated into and made a part of this Schedule 13D. The Pricing Agreement obligated the Company to undertake the following exchanges no later than December 31, 2001: (A) cancel 1,644,304 shares of the Series C Preferred Stock and in its place issue 1,849,057 shares of C-IV Preferred Stock, par value $0.01 per share ("Series C-IV Preferred"), and 4,099,678 shares of Series C-V Preferred Stock, par value $0.01 per share ("Series C-V Preferred"); and (B) cancel the Series C-1 Warrants to purchase 205,538 shares of Common Stock of the Company at an exercise price of $8.69 per share and the Series C-2 Warrants to purchase 205,538 shares of common stock at an exercise price of $10.86 per share and in their place issued 462,264 warrants with an exercise price of $2.65, subject to adjustment (the "Series C-IV Warrants"), and 1,024,920 warrants with an exercise price of $1.14, subject to adjustment (the "Series C-V Warrants"). On March 27, 2002, Travelers Indemnity received certificates from the Company for the Series C-IV and C-V Preferred and the Series C-IV and C-V warrants. The shares of the Series C-IV Preferred and the Series C-V Preferred are non-voting and may be converted at any time, without the payment of any additional consideration, shares of Common Stock. The Series C-IV Warrants and Series C-V Warrants may be exercised, at any time prior to 5 p.m. New York City time on March 14, 2005, to acquire shares of Common Stock at specified exercise prices. Pursuant to the terms of the Pricing Agreement, and in order to prevent a dilution of Travelers Indemnity's interest in the Company, the number of shares of Common Stock into which the Series C-IV Preferred and Series C-V Preferred are convertible and the number of shares of Common Stock that may be acquired on exercise of the Series C-IV Warrants and Series C-V Warrants that Travelers Indemnity beneficially owns (and the respective conversion or exercise prices per share of Common Stock) are subject to adjustment from time to time to reflect, among other events, certain issuances by the Compmany of Common Stock after September 8, 2000. As of March 31, 2002, according to information provided by the Company, Travelers Indemnity had the right to acquire 2,578,947 shares of Common Stock on conversion of Series C-IV Preferred Stock, 644,741 shares of Common Stock on exercise of Series C-IV Warrants, 5,227,552 shares of Common Stock on conversion of C-V Preferred Stock and 1,296,463 shares of Common Stock on exercise of Series C-V Warrants. The transactions described above were entered into for investment purposes. The Reporting Persons intend to review their investments in the Company from time to time. Depending on such review, the Reporting Persons may consider various alternative courses of action. Periodically, each of the Reporting Persons may determine to increase its investment or sell all or part of its investment in the Company through open-market purchases, privately negotiated transactions or otherwise. Such action is conditioned on prevailing market forces, including, without limitation, price and availability of shares of Common Stock, future evaluations by the Reporting Persons of the business and prospects of the Company, regulatory requirements, other investment opportunities available to the Reporting Persons and general stock market and economic conditions. Except as described in this Schedule 13D, none of the Reporting Persons nor, to the best knowledge of each Reporting Person, any of the persons named in Schedule A to this Schedule 13D, has formulated any plans or proposals which relate to or would result in: (a) the acquisition by any person of additional securities of the Company, or the disposition of securities of the Company; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Company or any of its subsidiaries; (c) a sale or transfer of a material amount of assets of the Company or any of its subsidiaries; (d) any change in the present Board of Directors or management of the Company, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the Board; (e) any material change in the present capitalization or dividend policy of the Company; (f) any other material change in the Company's business or corporate structure; (g) any changes in the Company's charter or by-laws or other actions which may impede the acquisition or control of the Company by any person; (h) causing a class of securities of the Company to be delisted from a national securities exchange or cease to be authorized to be quoted in an interdealer quotation system of a registered national securities association; (i) causing a class of equity securities of the Company to become eligible for termination of registration pursuant to Section 12(g)(4) of the Act; or (j) any action similar to those enumerated above. ITEM 5. INTEREST IN SECURITIES OF THE COMPANY. The response to Item 5 of the Schedule 13D is hereby amended and supplemented as follows: The percentages calculations in Item 5 of this Schedule 13D are based upon (1) 43,968,621 shares of Common Stock outstanding as of March 31, 2002 (based on information provided to the Reporting Persons by the Company) (2) 9,358,572 shares of Common Stock issuable to TIC and (3) 9,747,703 shares of Common Stock issuable to Travelers Indemnity. (a) TIC. As of March 31, 2002, TIC beneficially owns 10,958,572, or 20.5%, of the Company's Common Stock, as follows: (i) TIC is the direct beneficial owner of 1,600,000 shares of Common Stock; (ii) TIC is the indirect beneficial owner of 400,000 shares of Common Stock through ownership of 400,000 Preferred Stock Purchase Units, each of which may be converted into one share of Common Stock at any time; (iii) TIC is the indirect beneficial owner of 30,000 shares of Common Stock through ownership of stock options the Company granted to Jack L, Rivkin, a member of the Company's Board of Directors, at a time when Mr. Rivkin was an employee of a subsidiary of Citigroup (Mr. Rivkin has assigned his interest in the options to TIC); (iv) TIC is the indirect beneficial owner of 3,571,429 shares of Common Stock through ownership of 3,571,429 shares of the Company's Series C-VI Preferred Stock, each of which may be exchanged, subject to certain conditions, for one share of Common Stock; and (v) TIC is the indirect beneficial owner of 5,357,143 shares of Common Stock through ownership of 5,357,143 Series C-VI Warrants, each of which may be exchanged, subject to certain conditions, for one share of Common Stock at an exercise price of $0.56 per share. TIC disclaims beneficial ownership of the 12,682,295 shares of Common Stock held by Travelers Indemnity and the 12,160 shares of Common Stock held by other subsidiaries of Citigroup. TRAVELERS INDEMNITY. As of March 31, 2002, Travelers Indemnity beneficially owns 12,682,295 shares, or 23.9%, of the Company's Common Stock, as follows: (i) Travelers Indemnity is the direct beneficial owner of 2,934,592 shares of Common Stock; (ii) Travelers Indemnity is the indirect beneficial owner of 2,578,947 shares of Common Stock through ownership of 2,578,947 shares of Series C-IV Preferred Stock, each of which may be converted into one share of Common Stock at any time; (iii) Travelers Indemnity is the indirect beneficial owner of 644,741 shares of Common Stock through ownership of 644,741 Series C-IV Warrants, each of which may be exchanged, subject to certain conditions, for one share of Common Stock at an exercise price of $2.65 per share; (iv) Travelers Indemnity is the indirect beneficial owner of 5,227,552 shares of Common Stock through ownership of 5,227,552 shares of Series C-V Preferred Stock, each of which may be converted into one share of Common Stock at any time; and (v) Travelers Indemnity is the indirect beneficial owner of 1,296,463 shares of Common Stock through ownership of 1,296,463 Series C-V Warrants, each of which may be exchanged, subject to certain conditions, for one share of Common Stock at an exercise price of $1.14 per share. Travelers Indemnity disclaims beneficial ownership of the 10,918,572 shares of Common Stock held by TIC and the 12,160 shares of Common Stock held by other subsidiaries of Citigroup. TIGHI AND TAP. As of March 31, 2002, each of TIGHI and TAP indirectly beneficially owns, exclusively through their holding company structures, 12,682,295 shares, or 23.9%, of Common Stock representing the Common Stock beneficially owned by Travelers Indemnity. Each of TIGHI and TAP disclaims beneficial ownership of the 12,160 shares of Common Stock held by other subsidiaries of Citigroup. PFS AND ASSOCIATED MADISON. As of March 31, 2002, each of PFS and Associated Madison indirectly beneficially owns, exclusively through their holding company structures, 23,640,867 shares, or 37.8%, of Common Stock, representing (i) 10,958,572 shares beneficially owned by TIC and (ii) 12,682,295 shares beneficially owned by Travelers Indemnity. Each of PFS and Associated Madison disclaims beneficial ownership of the 12,160 shares of Common Stock held by other subsidiaries of Citigroup. CITIGROUP. As of March 31, 2002, Citigroup indirectly beneficially owns, exclusively through its holding company structure, 23,653,027 shares, or 37.8%, of Common Stock, representing (i) 10,958,572 shares beneficially owned by TIC, (ii) 12,682,295 shares beneficially owned by Travelers Indemnity and (iii) 12,160 shares beneficially owned by other subsidiaries of Citigroup. (b) TIC, PFS, Associated Madison and Citigroup may be deemed to share the voting and dispositive power of 10,958,572 shares of Common Stock beneficially owned by TIC. Travelers Indemnity, TIGHI, TAP, PFS, Associated Madison and Citigroup may be deemed to share the voting and dispositive power of 12,682,295 shares of Common Stock beneficially owned by Travelers Indemnity. Citigroup may be deemed to share the voting and dispositive power of 12,160 shares of Common Stock beneficially owned by other subsidiaries of Citigroup. This Schedule 13D is being filed because of TIGHI's 100% ownership interest in Travelers Indemnity, TAP's 100% ownership interest in TIGHI, PFS's 100% ownership interest in TIC and 77% ownership interest in TAP, Associated Madison's 100% ownership interest in PFS and Citigroup's 100% ownership interest in Associated Madison. (c) To the best knowledge of the Reporting Persons, none of the individuals named in Schedule A to this Schedule 13D has effected a transaction in shares of Common Stock during the past 60 days. In addition to the transactions set forth above in Item 4, the Reporting Persons effected the following transactions in shares of Common Stock during the past 60 days: TRAVELERS INDEMNITY. Travelers Indemnity sold (i) 130,125 shares of Common Stock at $0.38 per share on March 27, 2002 and (ii) 40,000 shares of Common Stock at $0.38 per share on March 28, 2002. (d) No person, other than TIC, has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock owned by TIC. No person, other than Travelers Indemnity, has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock owned by Travelers Indemnity. (e) Not applicable. ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO THE SECURITIES OF THE COMPANY. The response to Item 6 of the Schedule 13D is hereby amended and supplemented as follows: Jack L. Rivkin, who serves on the Company's Board of Directors, is no longer an employee of a subsidiary of Citigroup. Except as set forth in this Schedule 13D, to the best knowledge of the Reporting Persons, no contracts, arrangements, understandings or relationships (legal or otherwise) exist among the persons named in Item 2 or between such persons and any other person with respect to any securities of the Company, including, but not limited to, transfer or voting of any such securities, finder's fees, joint ventures, loan or option arrangements, puts or class, guarantees of profits, divisions of profits or loss, or the giving or withholding of proxies. ITEM 7. MATERIAL TO BE FILED AS EXHIBITS. EXHIBIT DESCRIPTION - ------- ----------- 1 Joint Filing Agreement among the Reporting Persons 2 Deferred Pricing Agreement, dated as of January 18, 2001, by and among On2 Technologies, Inc. and The Travelers Indemnity Company. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: April 12, 2002 THE TRAVELERS INDEMNITY COMPANY By: /s/ PAUL EDDY ----------------------------- Name: Paul Eddy Title: Assistant Secretary TRAVELERS PROPERTY CASUALTY CORP. By: /s/ PAUL EDDY ----------------------------- Name: Paul Eddy Title: Assistant Secretary TRAVELERS INSURANCE GROUP HOLDINGS INC. By: /s/ PAUL EDDY ----------------------------- Name: Paul Eddy Title: Assistant Secretary THE TRAVELERS INSURANCE COMPANY By: /s/ JOSEPH B. WOLLARD ----------------------------- Name: Joseph B. Wollard Title: Assistant Secretary PFS SERVICES, INC. By: /s/ JOSEPH B. WOLLARD ----------------------------- Name: Joseph B. Wollard Title: Assistant Secretary ASSOCIATED MADISON COMPANIES, INC. By: /s/ JOSEPH B. WOLLARD ----------------------------- Name: Joseph B. Wollard Title: Assistant Secretary CITIGROUP INC. By: /s/ JOSEPH B. WOLLARD ----------------------------- Name: Joseph B. Wollard Title: Assistant Secretary SCHEDULE A THE TRAVELERS INSURANCE COMPANY NAME TITLE - ---- ----- George C. Kokulis Director and Executive Officer Glenn D. Lammey Director and Executive Officer Marla Berman Lewitus Director and Executive Officer Kathleen A. Preston Director and Executive Officer Stuart L. Baritz Executive Officer Madelyn J. Lankton Executive Officer Brendan M. Lynch Executive Officer Warren H. May Executive Officer Laura A. Pantaleo Executive Officer David A. Tyson Executive Officer F. Denney Voss Executive Officer SCHEDULE A THE TRAVELERS INDEMNITY COMPANY NAME TITLE - ---- ----- Jay S. Benet Director and Executive Officer Charles J. Clarke Director and Executive Officer Douglas G. Elliott Director and Executive Officer Joseph P. Kiernan Director and Executive Officer Joseph P. Lacher, Jr. Director and Executive Officer Brian W. MacLean Director and Executive Officer James M. Michener Director and Executive Officer Peter N. Higgins Executive Officer Diana E. Beecher Executive Officer Susan Stonehill Claflin Executive Officer David A. Tyson Executive Officer F. Denney Voss Executive Officer W. Douglas Willett Executive Officer SCHEDULE A CITIGROUP INC. NAME TITLE - ---- ----- C. Michael Armstrong Director Alain J.P. Belda Director (Brazil) George David Director Kenneth T. Derr Director John M. Deutch Director The Honorable Gerald R. Ford Honorary Director Alfredo Harp Helu Director (Mexico) Roberto Hernandez Ramirez Director (Mexico) Ann Dibble Jordan Director Reuben Mark Director Michael T. Masin Director Dudley C. Mecum Director Richard D. Parsons Director Andrall E. Pearson Director Robert E. Rubin Director and Executive Officer Franklin A. Thomas Director Sanford I. Weill Director and Executive Officer Arthur Zankel Director Winfried F.W. Bischoff Executive Officer (United Kingdom and Germany) Michael A. Carpenter Executive Officer Thomas Wade Jones Executive Officer Deryck C. Maughan Executive Officer (United Kingdom) Victor J. Menezes Executive Officer Charles O. Prince, III Executive Officer William R. Rhodes Executive Officer Todd S. Thomson Executive Officer Robert B. Willumstad Executive Officer EXHIBIT LIST EXHIBIT DESCRIPTION - ------- ----------- 1 Joint Filing Agreement among the Reporting Persons 2 Deferred Pricing Agreement, dated as of January 18, 2001, by and among On2 Technologies, Inc. and The Travelers Indemnity Company. EX-1 3 a2076677zex-1.txt EXHIBIT 1 EXHIBIT 1 AGREEMENT AS TO JOINT FILING OF SCHEDULE 13D The undersigned hereby agree that: (i) each of them is individually eligible to use the Schedule 13D attached hereto; (ii) the attached Schedule 13D is filed on behalf of each of them; and (iii) each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information therein concerning him or itself; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless he or it knows or has reason to believe that such information is inaccurate. Dated: April 12, 2002 THE TRAVELERS INDEMNITY COMPANY By: /s/ PAUL EDDY ----------------------------- Name: Paul Eddy Title: Assistant Secretary TRAVELERS PROPERTY CASUALTY CORP. By: /s/ PAUL EDDY ----------------------------- Name: Paul Eddy Title: Assistant Secretary TRAVELERS INSURANCE GROUP HOLDINGS INC. By: /s/ PAUL EDDY ----------------------------- Name: Paul Eddy Title: Assistant Secretary THE TRAVELERS INSURANCE COMPANY By: /s/ JOSEPH B. WOLLARD ----------------------------- Name: Joseph B. Wollard Title: Assistant Secretary PFS SERVICES, INC. By: /s/ JOSEPH B. WOLLARD ----------------------------- Name: Joseph B. Wollard Title: Assistant Secretary ASSOCIATED MADISON COMPANIES, INC. By: /s/ JOSEPH B. WOLLARD ----------------------------- Name: Joseph B. Wollard Title: Assistant Secretary CITIGROUP INC. By: /s/ JOSEPH B. WOLLARD ----------------------------- Name: Joseph B. Wollard Title: Assistant Secretary EX-2 4 a2076677zex-2.txt EXHIBIT 2 EXHIBIT 2 DEFERRED PRICING AGREEMENT This DEFERRED PRICING AGREEMENT, dated as of January 18, 2001, by and among On2.com Inc., a Delaware corporation (the "Company"), and The Travelers Indemnity Company, a Delaware corporation ("Travelers"). WHEREAS, the parties hereto entered into a letter agreement, dated as of June 6, 2000 (the "Letter Agreement"), that provided for Travelers to have price and terms protection on its $10 million investment in Units (as defined in the Letter Agreement) relative to any other series of investment in the Units; and WHEREAS, the parties entered into a Preferred Stock Unit Subscription Agreement, dated as of June 6, 2000 (the "Subscription Agreement") and an Investor's Rights Agreement, dated as of June 7, 2000 (the "Investors Rights Agreement"); and WHEREAS, pursuant to the Subscription Agreement, Travelers invested $10.0 million in Units and received 1,644,304 shares of Series C Preferred Stock (the "Travelers Preferred Stock"), warrants to purchase 205,538 shares of common stock of the Company, par value $0.01 per share (the "Common Stock"), at an exercise price of $8.69 per share and warrants to purchase 205,538 shares of Common Stock at an exercise price of $10.86 per share (collectively, the "Travelers Warrants"); and WHEREAS, on September 29, 2000, certain investors invested $2.45 million in Units and received 924,527 shares of Series C-II Preferred Stock and warrants to purchase 369,037 shares of Common Stock at an exercise price of $2.65 per share; and WHEREAS, on December 8, 2000, certain investors invested $2.55 million in Units and received 2,049,839 shares of Series C-III Preferred Stock and warrants to purchase 635,450 shares of Common Stock at an exercise price of $1.14 per share; and WHEREAS, the parties desire to terminate the Letter Agreement upon execution of this Agreement. NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein, and intending to be legally bound thereby, the parties hereto hereby agree as follows: 1. PRICING ADJUSTMENT. (a) In full and complete satisfaction and discharge of the Company's obligations to Travelers under the Letter Agreement, upon the earlier of (i) a Change of Control (as defined below) or (ii) December 31, 2001, the Company shall (A) cancel the Travelers Preferred Stock and in its place issue 1,849,057 shares of Series C-IV Preferred Stock, par value $0.01 per share (the "Series C-IV Preferred Stock"), and 4,099,678 shares of Series C-V Preferred Stock, par value $0.01 per share (the "Series V Preferred Stock, and, together with the Series C-IV Preferred Stock, the "New Preferred Stock"), and (B) cancel the Travelers Warrants and in their place issue 462,264 warrants with an exercise price of $2.65 (the "C-IV Warrants") and 1,024,920 warrants with an exercise price of $1.14 (the "C-V Warrants" and, together with the C-IV Warrants, the "New Warrants"). (b) In order to receive the New Preferred Stock and the New Warrants in accordance with Section 1(a) hereof, Travelers must surrender the Travelers Preferred Stock and the Travelers Warrants to the Company for cancellation at its office at 145 Hudson Street, New York, New York 10013, or at such other place as is designated in writing by the Company. (c) For purposes of this Agreement, a "Change of Control" shall mean the first to occur of any of the following events: (i) any "person" or "group" (within the meaning of Sections 13(d) and 14(d)(2) of the Securities Act of 1933, as amended) other than Travelers and its affiliates, the Company, any trustee or other fiduciary holding Common Stock under an employee benefit plan of the Company or a related company, or any corporation which is owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of Common Stock, is or becomes the "beneficial owner" (as defined in Rule 13d-3 under the Securities Act of 1933, as amended) of more than fifty percent (50%) of the then outstanding voting stock of the Company; (ii) during any period of two consecutive years, individuals who at the beginning of such period constitute the Board of Directors of the Company (and any new director whose election by the Board of Directors or whose nomination for election by the Company's stockholders was approved by a vote of at least a majority of the directors then still in office who either were directors at the beginning of such period or whose election or nomination for election was previously so approved) cease for any reason to constitute a majority thereof; (iii) the merger or consolidation of the Company where the stockholders of the Company would not, immediately after the merger or consolidation, own at least fifty percent (50%) of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; (iv) the stockholders of the Company approve a plan of complete liquidation of the Company or an agreement for the sale or disposition by the Company of all or substantially all of the Company's assets; (v) the Company files a petition seeking protection from creditors under applicable bankruptcy laws, or an involuntary petition is filed under such laws that names the Company as debtor and has not been dismissed or stayed for a period of 30 days or more; or (vi) the Company ceases to conduct any business operations. 2. DESCRIPTION OF SECURITIES. The Series C-IV Preferred Stock and Series C-V Preferred Stock shall have the respective rights, preferences and limitations set forth in the respective Designations of Powers, Preferences and Rights of Preferred Stock attached hereto as EXHIBIT A and incorporated herein by reference. The forms of the C-IV Warrant and the C-V Warrant are attached hereto as EXHIBIT B and incorporated herein by reference. The Company agrees that any adjustment to the conversion price of the New Preferred Stock or to the exercise price of the New Warrants that is required by the terms of such securities will be given effect at the time of issuance even though the New Preferred Stock or New Warrants, as the case may be, were not yet issued and outstanding at the time of the event triggering such adjustment. 3. BRING-DOWN OF REPRESENTATIONS AND WARRANTIES. (a) With respect to the New Preferred Stock and the New Warrants, Travelers represents and warrants that the representations and warranties of Travelers contained in Section 2 of the Subscription Agreement are, and shall be, true and correct in all material respects on and as of the date hereof and the date (the "Closing Date") that the New Preferred Stock and the New Warrants are issued to Travelers, with the same effect as though such representations and warranties had been made on and as of the date hereof and such Closing Date. (b) The Company represents and warrants that on each Closing Date, the New Preferred Stock will be duly authorized, validly issued and outstanding, fully paid and non-assessable, the New Warrants will be duly authorized, validly issued and enforceable against the Company in accordance with their terms, and that no authorizations, approvals or consents will be required for the issuance or performance of the terms of the New Preferred Stock and the New Warrants by the Company. 4. TERMINATION OF LETTER AGREEMENT. The parties hereto acknowledge that the Letter Agreement is hereby terminated and shall be of no further force or effect. 5. FURTHER ASSURANCES. Upon the terms and subject to the conditions contained herein, the parties agree (i) to use all reasonable efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable to consummate and make effective the transactions contemplated by this Agreement; (ii) to execute any documents, instruments or conveyances of any kind that may be reasonably necessary or advisable to carry out any of the transactions contemplated hereunder; and (iii) to cooperate with each other in connection with the foregoing. 6. SUBSCRIPTION AGREEMENT AND INVESTOR'S RIGHTS AGREEMENT. Upon the issuance thereof, the New Preferred Stock and the New Warrants will constitute the Units, the Preferred Stock and the Warrants, as applicable, under the Subscription Agreement and the Investor's Rights Agreement. Other than the foregoing, all other provisions of the Subscription Agreement and the Investor's Rights Agreement shall remain in full force and effect. 7. ENTIRE AGREEMENT. This Agreement contains the entire agreement of the parties and supersedes all other agreements between the parties concerning the Travelers Preferred Stock, the Travelers Warrant, the New Preferred and the New Warrant. 8. MODIFICATION. This Agreement may only be modified by a written document signed by both parties. 9. GOVERNING LAW AND VENUE. This Agreement will be governed by and construed in accordance with the laws of the State of New York, without regard to any conflict of law provision. Any legal actions with respect to any matters arising under this Agreement shall be brought exclusively in a court of competent jurisdiction in New York, New York. 10. NO THIRD PARTY BENEFICIARIES. This Agreement is not intended to create any right, claim or remedy in favor of any person or entity, other than the parties hereto and their respective successors. 11. COUNTERPARTS. This Agreement may be executed in any number of counterparts, each of which shall be deemed and original, but all of which together shall constitute one and the same instrument. [Signature Page Follows] IN WITNESS WHEREOF, the parties named below have caused this Agreement to be duly executed and delivered as of the date first above written. ON2.COM INC. By: ------------------------------ Name: Title: THE TRAVELERS INDEMNITY COMPANY By: ------------------------------ Name: Title: EXHIBIT A Exhibit A-1 ON2.COM INC. --------------------------- DESIGNATION OF POWERS, PREFERENCES AND RIGHTS OF SERIES C-IV PREFERRED STOCK, PAR VALUE $0.01 PER SHARE --------------------------- Pursuant to Section 151(g) of the Delaware General Corporation Law --------------------------- IT IS HEREBY CERTIFIED that: 1. The name of the company (hereinafter called the "COMPANY") is On2.com Inc., a corporation organized and now existing under the Delaware General Corporation Law. 2. The Certificate of Incorporation of the Company (the "CERTIFICATE OF INCORPORATION") authorizes the issuance of Twenty Million (20,000,000) shares of preferred stock, par value $0.01 per share (the "PREFERRED STOCK"), and expressly vests in the Board of Directors of the Company the authority to issue any or all of said shares in one or more series by resolution or resolutions to establish the designation and number and to fix the relative rights and preferences of each series to be issued. 3. The Board of Directors of the Company, pursuant to the authority expressly vested in it as aforesaid, and pursuant to the provisions of Section 151(g) of the Delaware General Corporation Law, has adopted the resolution set forth below to create a series issue of Preferred Stock. Pursuant to 151(g), the approval of the Company's shareholders was not required. RESOLVED, THAT One Million Eight Hundred Forty-Nine Thousand Fifty-Seven (1,849,057) shares of the Twenty Million (20,000,000) shares of Preferred Stock of the Company which are authorized shares as of the date of this Certificate shall hereby be designated Series C-IV Preferred Stock, par value $0.01 per share, and shall possess the rights and preferences set forth below, which shall constitute a new Section 7E to Article IV of the Certificate of Incorporation: "Section 7E. Series C-IV Preferred Stock. 1. DESIGNATION AND AMOUNT. One Million Eight Hundred Forty-Nine Thousand Fifty-Seven (1,849,057) shares of the Twenty Million (20,000,000) authorized shares of Preferred Stock of the Company are designated Series C-IV Preferred Stock (the "SERIES C-IV PREFERRED STOCK"). The Series C-IV Preferred Stock shall be issued or offered at a purchase price equal to $2.65 per share (the "SERIES C-IV ORIGINAL ISSUE PRICE"). The holders of record of any series of the Series C-IV Preferred Stock are sometimes referred to in this Section 7E as the "SERIES C-IV HOLDERS." The holders of record of any shares of any series of the Preferred Stock are referred to in this Section 7E as the "HOLDERS." 2. RANK. The Series C-IV Preferred Stock shall rank on parity with the Company's Series A Preferred Stock, the Company's Series B Preferred Stock and any other subdivision of the Company's Series C Preferred Stock and shall accordingly rank (i) junior to any other class or series of capital stock of the Company hereafter created specifically ranking by its terms senior to the Series A Preferred Stock, the Series B Preferred Stock, the Series C-IV Preferred Stock or any other subdivision of the Series C Preferred Stock (the "SENIOR SECURITIES"); (ii) prior to all of the Common Stock; (iii) prior to any class or series of capital stock of the Company hereafter created not specifically ranking by its terms senior to or on parity with any Series A Preferred Stock, Series B Preferred Stock or Series C Preferred Stock of whatever subdivision (collectively, with the Common Stock, the "JUNIOR SECURITIES"); and (iv) on parity with any class or series of capital stock of the Company hereafter created specifically ranking by its terms on parity with the Series A Preferred Stock, the Series B Preferred Stock or any subdivision of the Series C Preferred Stock (the "PARITY SECURITIES") in each case as to distribution of assets upon any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary (all such distributions being referred to collectively as "DISTRIBUTIONS"). 3. LIQUIDATION PREFERENCE. (a) In the event of any Distribution, the Series C-IV Holders shall be entitled to receive, immediately after any distributions to the holders of the Senior Securities required by the Company's Certificate of Incorporation, and prior in preference to any distribution to the holders of the Junior Securities, but in parity with any Distribution to the holders of the Series A Preferred Stock (the "SERIES A HOLDERS"), the holders of the Series B Preferred Stock (the "SERIES B HOLDERS") or the holders of the Parity Securities, an amount per share equal to the Original Issue Price. If upon the occurrence of any such Distribution, and after payment in full of any preferential amounts due in respect of the Senior Securities, the assets and funds available to be distributed among the Series A Holders, the Series B Holders, the Series C-IV Holders and the holders of the Parity Securities shall be insufficient to pay to such Holders the full preferential amounts due to the Series A Holders, the Series B Holders, the Series C-IV Holders and holders of the Parity Securities, then the entire assets and funds of the Company legally available for distribution shall be distributed among the Series A Holders, the Series B Holders, the Series C-IV Holders and the holders of the Parity Securities, pro rata, based on the respective liquidation amounts to which each such series of stock is entitled by the Company's Certificate of Incorporation and any certificate(s) of designation relating thereto. (b) Upon the completion of the distribution required by Section 7E.3(a), if assets remain in the Company, they shall be distributed to holders of Junior Securities in accordance with the Company's Certificate of Incorporation, including any duly adopted certificate(s) of designation. (c) At the option of each Series C-IV Holder, a sale, conveyance or disposition of all or substantially all the assets of the Company to any entity other than an Affiliate of the Company which is controlled by the Company through the direct or indirect ownership of not less than 50% of the voting securities or interests thereof (a "Liquidating Transaction") shall be deemed to be a liquidation, dissolution or winding up within the meaning of this Section 7E.3; PROVIDED, that neither (i) any Liquidating Transaction that a Series C-IV Holder elects in writing not to treat as a liquidation, dissolution or winding up of the Company nor (ii) any consolidation, merger, acquisition, or other business combination of the Company with or into any other company or companies shall be treated as a liquidation, dissolution or winding up within the meaning of this Section 7E.3(c), but instead shall be subject to Section 7E.4(f). Any Series C-IV Holder as to which any Liquidating Transaction is treated as a liquidation, dissolution or winding up of the Company under this Section 7E.3(c) is referred to herein as a "SERIES C-IV LIQUIDATING HOLDER." (d) Prior to the closing of a transaction described in Section 7E.3(c) which would constitute a liquidation event, the Company shall either (i) make all cash distributions it is required to make to the Series C-IV Liquidating Holders pursuant to the first sentence of Section 7E.3(a), (ii) set aside sufficient funds from which the cash distributions required to be made to the Series C-IV Liquidating Holders can be made, or (iii) establish an escrow or other similar arrangement with a third party pursuant to which the proceeds payable to the Company from a sale of all or substantially all the assets of the Company will be used to make the liquidating payments to the Series C-IV Liquidating Holders immediately after the consummation of such sale. If the Company has not fully complied with any of the foregoing alternatives, the Company shall either: (x) cause such closing to be postponed until such cash distributions have been made, or (y) cancel such transaction, in which event the rights of the Series C-IV Holders or other arrangements shall be the same as existing immediately prior to such proposed transaction. 4. CONVERSION. The holders of Series C-IV Preferred Stock have conversion rights (the "Conversion Rights") as follows: (a) RIGHT TO CONVERT. Each share of Series C-IV Preferred Stock shall be convertible without the payment of any additional consideration at the option of the Series C-IV Holder thereof, at any time after the date of issuance of such shares of Series C-IV Preferred Stock, at the office of the Company or any transfer agent for the Series C-IV Preferred Stock into the number of fully paid and nonassessable shares of Common Stock which results from dividing the Series C-IV Original Issue Price by the conversion value per share in effect for each share of Series C-IV Preferred Stock (the "SERIES C-IV CONVERSION Value") at the time of conversion. The Series C-IV Conversion Value shall initially be equal to the Series C-IV Original Issue Price and shall be adjusted from time to time pursuant to the provisions of Section 7E.4(d) and Section 7E.4(e) and shall be subject to adjustment from time to time as provided below. The number of shares of Common Stock into which a share of Series C-IV Preferred Stock is convertible is hereinafter referred to as the "SERIES C-IV CONVERSION RATE." (b) MECHANICS OF CONVERSION. (i) No fractional shares of Common Stock shall be issued upon conversion of Series C-IV Preferred Stock. In lieu of any fractional shares to which the holder would otherwise be entitled, the Company shall pay cash equal to such fraction multiplied by the then effective Series C-IV Conversion Value. Before any holder of Series C-IV Preferred Stock shall be entitled to convert such shares into full shares of Common Stock and to receive certificates therefor, such holder shall surrender the certificate or certificates therefor, duly endorsed, at the office of the Company or of any transfer agent for the Series C-IV Preferred Stock, as the case may be, and shall give written notice to the Company at such office that such holder elects to convert the same; the Company shall, as soon as practicable thereafter, issue and deliver at such office to such holder a certificate or certificates for the number of shares of Common Stock to which such holder shall be entitled as aforesaid and a check payable to such holder in the amount of any cash amounts payable as the result of a conversion into fractional shares of Common Stock. Such conversion shall be deemed to have been made immediately prior to the close of business on the date of such surrender of the shares of Series C-IV Preferred Stock to be converted, and the person or persons entitled to receive the shares of Common Stock issuable upon such conversion shall be treated for all purposes as the record holder or holders of such shares of Common Stock on such date. (ii) The Company shall pay any and all issue and other taxes that may be payable in respect of any issuance or delivery of shares of Common Stock upon conversion of shares of Series C-IV Preferred Stock pursuant to this Section 7E.4. The Company shall not, however, be required to pay any tax which may be payable in respect of any transfer involving the issuance and delivery of shares of Common Stock in a name other than that in which the shares of Series C-IV Preferred Stock so converted were registered, and no such issuance or delivery shall be made unless and until the person or entity requesting such issuance has paid to the Company the amount of any tax or has established, to the satisfaction of the Company, that such tax has been paid. (c) RESERVATION OF STOCK ISSUABLE UPON CONVERSION. The Company shall at all times reserve and keep available out of its authorized but unissued shares of Common Stock solely for the purpose of effecting the conversion of the shares of Series C-IV Preferred Stock such number of its shares of Common Stock as shall from time to time be sufficient to effect the conversion of all outstanding shares of Series C-IV Preferred Stock; and if at any time the number of authorized but unissued shares of Common Stock shall not be sufficient to effect the conversion of all then outstanding shares of Series C-IV Preferred Stock, the Company shall take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares of Common Stock to such number of shares as shall be sufficient for such purposes. (d) ADJUSTMENTS TO SERIES C-IV CONVERSION VALUE FOR DILUTIVE ISSUANCES. (i) NO ADJUSTMENT OF CONVERSION PRICE. No adjustment in the Series C-IV Conversion Value shall be made in respect of the issuance of Additional Shares of Common Stock unless the consideration per share for an Additional Share of Common Stock issued or deemed to be issued by the Company is less than the Series C-IV Conversion Value as measured at the date of the issuance of the Additional Shares of Common Stock. No adjustment in the Series C-IV Conversion Value shall be made pursuant to Section 7E.4(d) as a result of any stock dividend or subdivision which causes an adjustment in the Series C-IV Conversion Value pursuant to Section 7E.4(e) or any event which is subject to the provisions of Section 7E.4(f). No adjustment in the Series C-IV Conversion Value shall be made in respect of an issuance or deemed issuance of Additional Shares of Common Stock if such issuance or deemed issuance involves the issuance or deemed issuance of stock, options or warrants (A) to employees, consultants or directors of the Company, (B) to other entities for acquisition purposes, (C) to banks or other institutional credit financing sources, or (D) the issuance of Common Stock upon conversion or redemption of any shares of any convertible series of the company's Preferred Stock; in the case of each of (A), (B) or (C) pursuant to plans or arrangements approved by the Board of Directors. (ii) DEEMED ISSUANCE OF ADDITIONAL SHARES OF COMMON STOCK. If the Company at any time or from time to time after September 8, 2000 shall issue any Options or Convertible Securities or shall fix a record date for the determination of holders of any class of securities entitled to receive any such Options or Convertible Securities, then the maximum number of shares (as set forth in the instrument relating thereto without regard to any provisions contained therein for a subsequent adjustment of such number) of Common Stock issuable upon the exercise of such Options or, in the case of Convertible Securities and Options therefor, the conversion or exchange of such Convertible Securities, shall be deemed to be Additional Shares of Common Stock issued as of the time of such issue or, in case such a record date shall have been fixed, as of the close of business on such record date; PROVIDED, that Additional Shares of Common Stock shall not be deemed to have been issued unless the consideration per share (determined pursuant to Section 7E.4(d)(iv)) of such Additional Shares of Common Stock would be less than the Series C-IV Conversion Value in effect on the date of and immediately prior to such issue (or with respect to any issues made prior to the date hereof, the Series C-IV Conversion Value that would have been in effect as of such date), or such record date, as the case may be; and PROVIDED, further, that in any case in which Additional Shares of Common Stock are deemed to be issued: (A) no further adjustment in the Series C-IV Conversion Value shall be made upon the subsequent issue of Convertible Securities or shares of Common Stock upon the exercise of such Options or conversion or exchange of such Convertible Securities; (B) if such Options or Convertible Securities by their terms provide, with the passage of time or otherwise, for any increase or decrease in the consideration payable to the Company, or any increase or decrease in the number of shares of Common Stock issuable, upon the exercise, conversion or exchange thereof, the Series C-IV Conversion Value computed upon the original issue of such Options or Convertible Securities (or upon the occurrence of a record date with respect to the issuance of such Options or Convertible Securities), and any subsequent adjustments based thereon shall, upon any such increase or decrease becoming effective, be recomputed to reflect such increase or decrease insofar as it affects such Options or the rights of conversion or exchange under such Convertible Securities; and (C) on the expiration or cancellation of any Options or the termination of the right to convert or exchange any Convertible Securities which shall have not been exercised, if the Series C-IV Conversion Value shall have been adjusted upon the original issuance of such Options or Convertible Securities or shall have been subsequently adjusted pursuant to clause (B) above, the Series C Conversion Value shall be recomputed as if: (1) in the case of Convertible Securities or Options for Common Stock, the only Additional Shares of Common Stock issued were the shares of Common Stock, if any, actually issued upon the exercise of such Options or the conversion or exchange of such Convertible Securities, and the consideration received therefor was the consideration actually received by the Company for the issuance of all such Options, whether or not exercised, plus the consideration actually received by the Company upon such exercise, if any, or for the issuance of all such Convertible Securities, whether or not actually converted or exchanged, plus the consideration actually received by the Company upon such conversion or exchange, if any; and (2) in the case of Options for Convertible Securities, only the Convertible Securities, if any, actually issued upon the exercise of such Options were issued at the time of issuance of such Options and the consideration received by the Company for the Additional Shares of Common Stock deemed to have been then issued was the consideration actually received by the Company for the issuance of all such Options, whether or not exercised, plus the consideration deemed to have been received by the Company upon the issuance of the Convertible Securities with respect to which such Options were actually exercised; (D) no readjustment pursuant to clauses (B) and (C) above shall have the effect of increasing the Series C-IV Conversion Value to an amount which exceeds the higher of (i) the Series C-IV Issue Price and (ii) the Series C Conversion Value that would have resulted from any issuance of Additional Shares of Common Stock between September 8, 2000 and the date of such readjustment. (iii) ADJUSTMENT OF SERIES C CONVERSION VALUE UPON ISSUANCE OF ADDITIONAL SHARES OF COMMON STOCK. If at any time after September 8, 2000 the Company shall issue (or shall have issued in the case of issuances after September 8, 2000 but prior to the date hereof) Additional Shares of Common Stock (including Additional Shares of Common Stock deemed to be issued pursuant to Section 7E.4(d)(ii)) without consideration or for a consideration per share less than the Series C-IV Conversion Value in effect on the date of and immediately prior to such issuance, then and in such event, the Series C-IV Conversion Value shall be reduced, concurrently with such issuance, to a price (calculated to the nearest one cent) determined by dividing (A) an amount equal to the sum of (x) the number of shares of Common Stock outstanding immediately prior to such issue (determined on a fully-diluted basis; I.E. treating as outstanding all shares of Common Stock issuable upon exercise, exchange or conversion of all outstanding options (to the extent then vested or exercisable), warrants or other securities exercisable or exchangeable for or convertible into, directly or indirectly, shares of Common Stock) multiplied by the then existing Series C-IV Conversion Value, plus (y) the consideration, if any, received by the Company (or deemed to have been received by the Company) upon such issue of Additional Shares of Common Stock, by (B) the sum of the number of shares of the Company's issued and outstanding Common Stock on a fully-diluted basis immediately before the issuance of such Additional Shares of Common Stock plus the number of shares of Additional Shares of Common Stock that were issued (or deemed to have been issued). Notwithstanding the foregoing provisions of this Section, if the operation of the foregoing provisions shall result in a new Series C-IV Conversion Value which is less than or equal to the price paid or deemed to have been paid for such Additional Shares of Common Stock (the "Additional Shares Issue Price"), then the new Series C-IV Conversion Value shall be the amount which is $0.01 more than the Additional Shares Issue Price. If such Additional Shares of Common Stock are issued for no consideration, then the Additional Shares Issue Price shall be deemed to be $0.01. (iv) DETERMINATION OF CONSIDERATION. For purposes of this Section 7E.4(d), the consideration received by the Company for the issuance of any Additional Shares of Common Stock shall be computed as follows: (A) CASH AND PROPERTY. Such consideration shall: (1) insofar as it consists of cash, be computed at the aggregate amount of cash received by the Company; (2) insofar as it consists of securities (i) if the securities are then traded on a national securities exchange or the NASDAQ Stock Market (or a similar national quotation system), then the value shall be computed based on the average of the closing prices of the securities on such exchange or system over the 30-day period ending three days prior to receipt of such securities by the Company, (ii) if the securities are actively traded over-the-counter, then the value shall be computed based on the average of the closing bid prices over the 30-day period ending three days prior to the receipt of such securities by the Company, and (iii) if there is no active public market, then the value shall be computed based on the fair market value thereof on the date of receipt of such securities by the Company, as determined in good faith by the Board of Directors; (3) insofar as it consists of property other than cash and securities, be computed at the fair market value thereof at the time of such issuance, as determined in good faith by the Board of Directors; and (4) if Additional Shares of Common Stock are issued together with other shares or securities or other assets of the Company for consideration which covers both, be the proportion of such consideration so received for such Additional Shares of Common Stock, computed as provided in clauses (A)(1), (A)(2) and (A)(3) of this Section 7E.4(d)(iv), in each case as determined in good faith by the Board of Directors. (B) OPTIONS AND CONVERTIBLE SECURITIES. The consideration per share received by the Company for Additional Shares of Common Stock deemed to have been issued pursuant to Section 7E.4(d)(ii), relating to Options and Convertible Securities, shall be determined by dividing (1) the total amount, if any, received or receivable by the Company as consideration for the issue of such Options or Convertible Securities, plus the minimum aggregate amount of additional consideration (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such consideration) payable to the Company upon the exercise of such Options or the conversion or exchange of such Convertible Securities, or, in the case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities by (2) the maximum number of shares of Common Stock (as set forth in the instrument relating thereto, without regard to any provision contained therein for a subsequent adjustment of such number) issuable upon the exercise of such Options or the conversion or exchange of such Convertible Securities. (e) ADJUSTMENT TO THE CONVERSION RATE DUE TO STOCK SPLIT, STOCK DIVIDEND OR OTHER SIMILAR EVENT. If, prior to the conversion of all the Series C-IV Preferred Stock, the number of outstanding shares of Common Stock is increased by a stock split, stock dividend or other similar event, the Series C-IV Conversion Value shall be proportionately reduced, or if the number of outstanding shares of Common Stock is decreased by a combination or reclassification of shares, or other similar event, the Series C-IV Conversion Value shall be proportionately increased. (f) ADJUSTMENT DUE TO CONSOLIDATION, MERGER, EXCHANGE OF SHARES, RECAPITALIZATION, REORGANIZATION OR OTHER SIMILAR EVENT. If, prior to the conversion of all the Series C-IV Preferred Stock, (i) there shall be any merger, consolidation, exchange of shares, recapitalization, reorganization or other similar event, as a result of which shares of Common Stock of the Company shall be changed into the same or a different number of shares of the same or another class or classes of stock or securities of the Company or another entity, or (ii) there occurs a sale of all or substantially all of the Company's assets that is not deemed to be a liquidation, dissolution or winding up of the Company pursuant to Section 7E.3(c), then the Series C-IV Holders thereafter shall have the right to receive upon conversion of the shares of Series C-IV Preferred Stock held by them, upon the basis and upon the terms and conditions specified herein and in lieu of the shares of Common Stock immediately theretofore issuable upon conversion, such stock, securities and/or other assets which the Series C-IV Holders would have been entitled to receive in such transaction had the Series C-IV Preferred Stock been converted immediately prior to such transaction, and in any such case appropriate provisions shall be made with respect to the rights and interests of the Series C-IV Holders to the end that the provisions hereof (including, without limitation, provisions for the adjustment of the Series C-IV Conversion Value and the Series C-IV Conversion Rate shall thereafter be applicable, as nearly as may be practicable in relation to any securities thereafter deliverable upon the exercise hereof. (g) CERTIFICATES AS TO ADJUSTMENTS. Upon each adjustment or readjustment of the Series C-IV Conversion Value pursuant to Sections 7E.4(d), (e) and (f) above, and upon the initial issue of Series C-IV Preferred Stock, if any adjustment or readjustment would have occurred prior thereto (but after September 8, 2000) pursuant to the terms hereof, the Company at its expense promptly shall compute such adjustment or readjustment in accordance with the terms hereof and prepare and furnish to each holder of Series C-IV Preferred Stock a certificate of the Chief Financial Officer of the Company setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Company shall, upon the written request at any time of any holder of Series C-IV Preferred Stock, furnish or cause to be furnished to such holder a like certificate setting forth (i) such adjustments and readjustments, (ii) the then effective Series C-IV Conversion Value, and (iii) the number of shares of Common Stock and the amount, if any, of other property which at the time would be received upon the conversion of each share of such Series C-IV Preferred Stock. (h) NO IMPAIRMENT. The Company will not, by amendment of its Certificate of Incorporation or through any reorganization, transfer of assets, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist in the carrying out of all the provisions of this Section 7E and in the taking of all such action as may be necessary or appropriate to protect the Conversion Rights against impairment. (i) DEFINITIONS. As used in this Section 7E, the following terms shall have the following meanings: "ADDITIONAL SHARES OF COMMON STOCK" shall mean all shares of Common Stock issued (or, pursuant to Section 7E.4(d)(ii), deemed to be issued) by the Company after September 8, 2000, other than shares of Common Stock issued or issuable: (i) upon conversion of shares of Series C-IV Preferred Stock; (ii) to officers, directors or employees of, or financial advisors or other consultants to, the Company pursuant to a Plan or Plans or pursuant to any acquisition, financing or other written agreement so long as any such Plan or written agreement has been approved by the Board of Directors (including at least one of the members of the Board of Directors designated by the holders of the Series C-IV Preferred Stock while such holders have the right to designate one or more directors); and (iii) as a dividend or distribution on Series C-IV Preferred Stock. "AFFILIATE" shall have the meaning given such term in Rule 405 promulgated under the Securities Act. "COMMON STOCK" shall mean the common stock, no par value, of the Company. "CONVERSION RIGHTS" shall mean the rights to convert Series C-IV Preferred Stock into Common Stock as provided in this Section 7E. "CONVERTIBLE SECURITIES" shall mean any evidences of indebtedness, shares (other than Common Stock or Series C-IV Preferred Stock) or other securities convertible into or exchangeable for Common Stock. "OPTIONS" shall mean rights, options or warrants to subscribe for, purchase or otherwise acquire either Common Stock or Convertible Securities. "ORIGINAL ISSUE DATE" shall mean _____, 200_ [to be the date the Series C-IV Preferred Stock is issued]. "ORIGINAL PURCHASE PRICE" shall mean the original purchase price of $2.65 per share for each share of Series C-IV Preferred Stock, as such amount shall be adjusted for all stock splits, combinations, consolidations, stock distributions, stock dividends or other recapitalization transactions involving the Series C-IV Preferred Stock. "PLAN" shall mean a written stock grant, option plan or purchase plan or other employee stock incentive program. "PREFERRED STOCK" shall mean the preferred stock, par value $.01 per share, of the Company. "SECURITIES ACT" shall mean the Securities Act of 1933, as amended. "SERIES C-IV CONVERSION RATE" shall mean the number of shares of Common Stock into which a share of Series C-IV Preferred Stock is convertible. "SERIES C-IV CONVERSION VALUE" shall have the meaning given such term in Section 7E.4(a). "SERIES C-IV PREFERRED STOCK" shall mean those authorized shares of Preferred Stock of the Company designated as "Series C-IV Preferred Stock", par value $0.01 per share. 5. OPTIONAL REDEMPTION OF SERIES C-IV PREFERRED STOCK. The Company may, at any time after ______, 200_ [Three years from issue date], and from time to time, call for redemption and repurchase of any and all shares of Series C-IV Preferred Stock for a purchase price per share equal to the Series C-IV Original Issue Price. The Company shall give written notice via certified mail, and any Series C-IV Holder shall have the right to convert the shares of Series C-IV Preferred Stock held by it at any time prior to the payment date specified in such notice. Any such redemption and repurchase shall be made from funds legally available for such purpose and which are not otherwise restricted. 6. VOTING RIGHTS. The Series C-IV Holders shall have no voting power whatsoever except to the extent otherwise expressly provided by the Delaware General Corporation Law, and no Series C-IV Holder shall vote or otherwise participate in any proceeding in which actions shall be taken by the Company or the stockholders thereof or be entitled to notification as to any meeting of the stockholders. 7. PROTECTIVE PROVISION. So long as shares of Series C-IV Preferred Stock are outstanding, the Company shall not without first obtaining the approval (by vote or written consent, as provided by the Delaware General Corporation Law) of the holders of at least a majority of the then outstanding shares of Series C-IV Preferred Stock: (a) alter or change the rights, preferences or privileges of the Series C-IV Preferred Stock, including, but not limited to, the creation or authorization of any Senior Securities. (b) increase the size of the authorized number of Series C-IV Preferred Stock; or (c) do any act or thing not authorized or contemplated by this Certificate of Incorporation which would result in taxation of the Series C-IV Holders under Section 305 of the Internal Revenue Code of 1986, as amended (or any comparable provision of the Internal Revenue Code as hereafter from time to time amended). If the holders of a majority of the then outstanding shares of Series C-IV Preferred Stock agree to allow the Company to alter or change the rights, preferences or privileges of the shares of Series C-IV Preferred Stock, pursuant to Subsection (a) above, so as to affect adversely the Series C-IV Preferred Stock, then the Company will deliver notice of such approved alteration or change to the Series C-IV Holders that did not agree to such alteration or change (the "SERIES C-IV DISSENTING HOLDERS"), and the Series C-IV Dissenting Holders shall thereafter have the right for a period of 30 days to convert pursuant to the terms of this Certificate of Incorporation as they exist prior to such alteration or change or continue to hold their shares of Series C-IV Preferred Stock subject to the approved alteration or change of the rights, preferences or privileges of the Series C-IV Preferred Stock. 8. STATUS OF CONVERTED STOCK. In the event any shares of Series C-IV Preferred Stock shall be converted pursuant to Section 7E.4, the shares so converted shall be canceled, shall return to the status of authorized but unissued preferred stock of no designated series, and shall not be issuable by the Company as Series C-IV Preferred Stock. 9. PREFERENCE RIGHTS. Nothing contained herein shall be construed to prevent the Board of Directors of the Company from issuing one or more series of preferred stock with dividend and/or liquidation preferences on parity with or junior to the dividend and liquidation preferences of the Series C-IV Preferred Stock. IN WITNESS WHEREOF, this Certificate of Designations have been duly adopted by the Board of Directors of the Company and have been duly executed on behalf of the Company by its Secretary this ____ day of _____, 200_. ON2.COM INC. By: ---------------------------------- Secretary Attestation: - ----------------------------- Name: Exhibit A-2 ON2.COM INC. --------------------------- DESIGNATION OF POWERS, PREFERENCES AND RIGHTS OF SERIES C-V PREFERRED STOCK, PAR VALUE $0.01 PER SHARE --------------------------- Pursuant to Section 151(g) of the Delaware General Corporation Law --------------------------- IT IS HEREBY CERTIFIED that: 1. The name of the company (hereinafter called the "COMPANY") is On2.com Inc., a corporation organized and now existing under the Delaware General Corporation Law. 2. The Certificate of Incorporation of the Company (the "CERTIFICATE OF INCORPORATION") authorizes the issuance of Twenty Million (20,000,000) shares of preferred stock, par value $0.01 per share (the "PREFERRED STOCK"), and expressly vests in the Board of Directors of the Company the authority to issue any or all of said shares in one or more series by resolution or resolutions to establish the designation and number and to fix the relative rights and preferences of each series to be issued. 3. The Board of Directors of the Company, pursuant to the authority expressly vested in it as aforesaid, and pursuant to the provisions of Section 151(g) of the Delaware General Corporation Law, has adopted the resolution set forth below to create a series issue of Preferred Stock. Pursuant to 151(g), the approval of the Company's shareholders was not required. RESOLVED, THAT Four Million Ninety-Nine Thousand Six Hundred Seventy-Eight (4,099,678) shares of the Twenty Million (20,000,000) shares of Preferred Stock of the Company which are authorized shares as of the date of this Certificate shall hereby be designated Series C-V Preferred Stock, par value $0.01 per share, and shall possess the rights and preferences set forth below, which shall constitute a new Section 7F to Article IV of the Certificate of Incorporation: "Section 7F. Series C-V Preferred Stock. 1. DESIGNATION AND AMOUNT. Four Million Ninety-Nine Thousand Six Hundred Seventy-Eight (4,099,678) shares of the Twenty Million (20,000,000) authorized shares of Preferred Stock of the Company are designated Series C-V Preferred Stock (the "SERIES C-V PREFERRED STOCK"). The Series C-V Preferred Stock shall be issued or offered at a purchase price equal to $1.24 per share (the "SERIES C-V ORIGINAL ISSUE PRICE"). The holders of record of any series of the Series C-V Preferred Stock are sometimes referred to in this Section 7F as the "SERIES C-V HOLDERS." The holders of record of any shares of any series of the Preferred Stock are referred to in this Section 7F as the "HOLDERS." 2. RANK. The Series C-V Preferred Stock shall rank on parity with the Company's Series A Preferred Stock, the Company's Series B Preferred Stock and any other subdivision of the Company's Series C Preferred Stock and shall accordingly rank (i) junior to any other class or series of capital stock of the Company hereafter created specifically ranking by its terms senior to the Series A Preferred Stock, the Series B Preferred Stock, the Series C-V Preferred Stock or any other subdivision of the Series C Preferred Stock (the "SENIOR SECURITIES"); (ii) prior to all of the Common Stock; (iii) prior to any class or series of capital stock of the Company hereafter created not specifically ranking by its terms senior to or on parity with any Series A Preferred Stock, Series B Preferred Stock or Series CPreferred Stock of whatever subdivision (collectively, with the Common Stock, the "JUNIOR SECURITIES"); and (iv) on parity with any class or series of capital stock of the Company hereafter created specifically ranking by its terms on parity with the Series A Preferred Stock, the Series B Preferred Stock or any subdivision of the Series C Preferred Stock (the "PARITY SECURITIES") in each case as to distribution of assets upon any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary (all such distributions being referred to collectively as "DISTRIBUTIONS"). 3. LIQUIDATION PREFERENCE. (a) In the event of any Distribution, the Series C-V Holders shall be entitled to receive, immediately after any distributions to the holders of the Senior Securities required by the Company's Certificate of Incorporation, and prior in preference to any distribution to the holders of the Junior Securities, but in parity with any Distribution to the holders of the Series A Preferred Stock (the "SERIES A HOLDERS"), the holders of the Series B Preferred Stock (the "SERIES B HOLDERS") or the holders of the Parity Securities, an amount per share equal to the Original Issue Price. If upon the occurrence of any such Distribution, and after payment in full of any preferential amounts due in respect of the Senior Securities, the assets and funds available to be distributed among the Series A Holders, the Series B Holders, the Series C-V Holders and the holders of the Parity Securities shall be insufficient to pay to such Holders the full preferential amounts due to the Series A Holders, the Series B Holders, the Series C-V Holders and holders of the Parity Securities, then the entire assets and funds of the Company legally available for distribution shall be distributed among the Series A Holders, the Series B Holders, the Series C-V Holders and the holders of the Parity Securities, pro rata, based on the respective liquidation amounts to which each such series of stock is entitled by the Company's Certificate of Incorporation and any certificate(s) of designation relating thereto. (b) Upon the completion of the distribution required by Section 7F.3(a), if assets remain in the Company, they shall be distributed to holders of Junior Securities in accordance with the Company's Certificate of Incorporation, including any duly adopted certificate(s) of designation. (c) At the option of each Series C-V Holder, a sale, conveyance or disposition of all or substantially all the assets of the Company to any entity other than an Affiliate of the Company which is controlled by the Company through the direct or indirect ownership of not less than 50% of the voting securities or interests thereof (a "Liquidating Transaction") shall be deemed to be a liquidation, dissolution or winding up within the meaning of this Section 7F.3; PROVIDED, that neither (i) any Liquidating Transaction that a Series C-V Holder elects in writing not to treat as a liquidation, dissolution or winding up of the Company nor (ii) any consolidation, merger, acquisition, or other business combination of the Company with or into any other company or companies shall be treated as a liquidation, dissolution or winding up within the meaning of this Section 7F.3(c), but instead shall be subject to Section 7F.4(f). Any Series C-V Holder as to which any Liquidating Transaction is treated as a liquidation, dissolution or winding up of the Company under this Section 7F.3(c) is referred to herein as a "SERIES C-V LIQUIDATING HOLDER." (d) Prior to the closing of a transaction described in Section 7F.3(c) which would constitute a liquidation event, the Company shall either (i) make all cash distributions it is required to make to the Series C-V Liquidating Holders pursuant to the first sentence of Section 7F.3(a), (ii) set aside sufficient funds from which the cash distributions required to be made to the Series C-V Liquidating Holders can be made, or (iii) establish an escrow or other similar arrangement with a third party pursuant to which the proceeds payable to the Company from a sale of all or substantially all the assets of the Company will be used to make the liquidating payments to the Series C-V Liquidating Holders immediately after the consummation of such sale. If the Company has not fully complied with any of the foregoing alternatives, the Company shall either: (x) cause such closing to be postponed until such cash distributions have been made, or (y) cancel such transaction, in which event the rights of the Series C-V Holders or other arrangements shall be the same as existing immediately prior to such proposed transaction. 4. CONVERSION. The holders of Series C-V Preferred Stock have conversion rights (the "Conversion Rights") as follows: (f) RIGHT TO CONVERT. Each share of Series C-V Preferred Stock shall be convertible without the payment of any additional consideration at the option of the Series C-V Holder thereof, at any time after the date of issuance of such shares of Series C-V Preferred Stock, at the office of the Company or any transfer agent for the Series C-V Preferred Stock into the number of fully paid and nonassessable shares of Common Stock which results from dividing the Series C-V Original Issue Price by the conversion value per share in effect for each share of Series C-V Preferred Stock (the "SERIES C-V CONVERSION VALUE") at the time of conversion. The Series C-V Conversion Value shall initially be equal to the Series C-V Original Issue Price and shall be adjusted from time to time pursuant to the provisions of Section 7F.4(d) and Section 7F.4(e) and shall be subject to adjustment from time to time as provided below. The number of shares of Common Stock into which a share of Series C-V Preferred Stock is convertible is hereinafter referred to as the "SERIES C-V CONVERSION RATE." (g) MECHANICS OF CONVERSION. (i) No fractional shares of Common Stock shall be issued upon conversion of Series C-V Preferred Stock. In lieu of any fractional shares to which the holder would otherwise be entitled, the Company shall pay cash equal to such fraction multiplied by the then effective Series C-V Conversion Value. Before any holder of Series C-V Preferred Stock shall be entitled to convert such shares into full shares of Common Stock and to receive certificates therefor, such holder shall surrender the certificate or certificates therefor, duly endorsed, at the office of the Company or of any transfer agent for the Series C-V Preferred Stock, as the case may be, and shall give written notice to the Company at such office that such holder elects to convert the same; the Company shall, as soon as practicable thereafter, issue and deliver at such office to such holder a certificate or certificates for the number of shares of Common Stock to which such holder shall be entitled as aforesaid and a check payable to such holder in the amount of any cash amounts payable as the result of a conversion into fractional shares of Common Stock. Such conversion shall be deemed to have been made immediately prior to the close of business on the date of such surrender of the shares of Series C-V Preferred Stock to be converted, and the person or persons entitled to receive the shares of Common Stock issuable upon such conversion shall be treated for all purposes as the record holder or holders of such shares of Common Stock on such date. (ii) The Company shall pay any and all issue and other taxes that may be payable in respect of any issuance or delivery of shares of Common Stock upon conversion of shares of Series C-V Preferred Stock pursuant to this Section 7F.4. The Company shall not, however, be required to pay any tax which may be payable in respect of any transfer involving the issuance and delivery of shares of Common Stock in a name other than that in which the shares of Series C-V Preferred Stock so converted were registered, and no such issuance or delivery shall be made unless and until the person or entity requesting such issuance has paid to the Company the amount of any tax or has established, to the satisfaction of the Company, that such tax has been paid. (h) RESERVATION OF STOCK ISSUABLE UPON CONVERSION. The Company shall at all times reserve and keep available out of its authorized but unissued shares of Common Stock solely for the purpose of effecting the conversion of the shares of Series C-V Preferred Stock such number of its shares of Common Stock as shall from time to time be sufficient to effect the conversion of all outstanding shares of Series C-V Preferred Stock; and if at any time the number of authorized but unissued shares of Common Stock shall not be sufficient to effect the conversion of all then outstanding shares of Series C-V Preferred Stock, the Company shall take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares of Common Stock to such number of shares as shall be sufficient for such purposes. (i) ADJUSTMENTS TO SERIES C-V CONVERSION VALUE FOR DILUTIVE ISSUANCES. (i) NO ADJUSTMENT OF CONVERSION PRICE. No adjustment in the Series C-V Conversion Value shall be made in respect of the issuance of Additional Shares of Common Stock unless the consideration per share for an Additional Share of Common Stock issued or deemed to be issued by the Company is less than the Series C-V Conversion Value as measured at the date of the issuance of the Additional Shares of Common Stock. No adjustment in the Series C-V Conversion Value shall be made pursuant to Section 7F.4(d) as a result of any stock dividend or subdivision which causes an adjustment in the Series C-V Conversion Value pursuant to Section 7F.4(e) or any event which is subject to the provisions of Section 7F.4(f). No adjustment in the Series C-V Conversion Value shall be made in respect of an issuance or deemed issuance of Additional Shares of Common Stock if such issuance or deemed issuance involves the issuance or deemed issuance of stock, options or warrants (A) to employees, consultants or directors of the Company, (B) to other entities for acquisition purposes, (C) to banks or other institutional credit financing sources, or (D) the issuance of Common Stock upon conversion or redemption of any shares of any convertible series of the company's Preferred Stock; in the case of each of (A), (B) or (C) pursuant to plans or arrangements approved by the Board of Directors. (ii) DEEMED ISSUANCE OF ADDITIONAL SHARES OF COMMON STOCK. If the Company at any time or from time to time after September 8, 2000 shall issue any Options or Convertible Securities or shall fix a record date for the determination of holders of any class of securities entitled to receive any such Options or Convertible Securities, then the maximum number of shares (as set forth in the instrument relating thereto without regard to any provisions contained therein for a subsequent adjustment of such number) of Common Stock issuable upon the exercise of such Options or, in the case of Convertible Securities and Options therefor, the conversion or exchange of such Convertible Securities, shall be deemed to be Additional Shares of Common Stock issued as of the time of such issue or, in case such a record date shall have been fixed, as of the close of business on such record date; PROVIDED, that Additional Shares of Common Stock shall not be deemed to have been issued unless the consideration per share (determined pursuant to Section 7F.4(d)(iv)) of such Additional Shares of Common Stock would be less than the Series C-V Conversion Value in effect on the date of and immediately prior to such issue (or with respect to any issues made prior to the date hereof, the Series C-V Conversion Value that would have been in effect as of such date), or such record date, as the case may be; and PROVIDED, further, that in any case in which Additional Shares of Common Stock are deemed to be issued: (A) no further adjustment in the Series C-V Conversion Value shall be made upon the subsequent issue of Convertible Securities or shares of Common Stock upon the exercise of such Options or conversion or exchange of such Convertible Securities; (B) if such Options or Convertible Securities by their terms provide, with the passage of time or otherwise, for any increase or decrease in the consideration payable to the Company, or any increase or decrease in the number of shares of Common Stock issuable, upon the exercise, conversion or exchange thereof, the Series C-V Conversion Value computed upon the original issue of such Options or Convertible Securities (or upon the occurrence of a record date with respect to the issuance of such Options or Convertible Securities), and any subsequent adjustments based thereon shall, upon any such increase or decrease becoming effective, be recomputed to reflect such increase or decrease insofar as it affects such Options or the rights of conversion or exchange under such Convertible Securities; and (C) on the expiration or cancellation of any Options or the termination of the right to convert or exchange any Convertible Securities which shall have not been exercised, if the Series C-V Conversion Value shall have been adjusted upon the original issuance of such Options or Convertible Securities or shall have been subsequently adjusted pursuant to clause (B) above, the Series C Conversion Value shall be recomputed as if: (1) in the case of Convertible Securities or Options for Common Stock, the only Additional Shares of Common Stock issued were the shares of Common Stock, if any, actually issued upon the exercise of such Options or the conversion or exchange of such Convertible Securities, and the consideration received therefor was the consideration actually received by the Company for the issuance of all such Options, whether or not exercised, plus the consideration actually received by the Company upon such exercise, if any, or for the issuance of all such Convertible Securities, whether or not actually converted or exchanged, plus the consideration actually received by the Company upon such conversion or exchange, if any; and (2) in the case of Options for Convertible Securities, only the Convertible Securities, if any, actually issued upon the exercise of such Options were issued at the time of issuance of such Options and the consideration received by the Company for the Additional Shares of Common Stock deemed to have been then issued was the consideration actually received by the Company for the issuance of all such Options, whether or not exercised, plus the consideration deemed to have been received by the Company upon the issuance of the Convertible Securities with respect to which such Options were actually exercised; (D) no readjustment pursuant to clauses (B) and (C) above shall have the effect of increasing the Series C-V Conversion Value to an amount which exceeds the higher of (i) the Series C-V Issue Price and (ii) the Series C Conversion Value that would have resulted from any issuance of Additional Shares of Common Stock between September 8, 2000 and the date of such readjustment. (iii) ADJUSTMENT OF SERIES C CONVERSION VALUE UPON ISSUANCE OF ADDITIONAL SHARES OF COMMON STOCK. If at any time after September 8, 2000 the Company shall issue (or shall have issued in the case of issuances after September 8, 2000 but prior to the date hereof) Additional Shares of Common Stock (including Additional Shares of Common Stock deemed to be issued pursuant to Section 7F.4(d)(ii)) without consideration or for a consideration per share less than the Series C-V Conversion Value in effect on the date of and immediately prior to such issuance, then and in such event, the Series C-V Conversion Value shall be reduced, concurrently with such issuance, to a price (calculated to the nearest one cent) determined by dividing (A) an amount equal to the sum of (x) the number of shares of Common Stock outstanding immediately prior to such issue (determined on a fully-diluted basis; I.E. treating as outstanding all shares of Common Stock issuable upon exercise, exchange or conversion of all outstanding options (to the extent then vested or exercisable), warrants or other securities exercisable or exchangeable for or convertible into, directly or indirectly, shares of Common Stock) multiplied by the then existing Series C-V Conversion Value, plus (y) the consideration, if any, received by the Company (or deemed to have been received by the Company) upon such issue of Additional Shares of Common Stock, by (B) the sum of the number of shares of the Company's issued and outstanding Common Stock on a fully-diluted basis immediately before the issuance of such Additional Shares of Common Stock plus the number of shares of Additional Shares of Common Stock that were issued (or deemed to have been issued). Notwithstanding the foregoing provisions of this Section, if the operation of the foregoing provisions shall result in a new Series C-V Conversion Value which is less than or equal to the price paid or deemed to have been paid for such Additional Shares of Common Stock (the "Additional Shares Issue Price"), then the new Series C-V Conversion Value shall be the amount which is $0.01 more than the Additional Shares Issue Price. If such Additional Shares of Common Stock are issued for no consideration, then the Additional Shares Issue Price shall be deemed to be $0.01. (iv) DETERMINATION OF CONSIDERATION. For purposes of this Section 7F.4(d), the consideration eceived by the Company for the issuance of any Additional Shares of Common Stock shall be computed as follows: (A) CASH AND PROPERTY. Such consideration shall: (1) insofar as it consists of cash, be computed at the aggregate amount of cash received by the Company; (2) insofar as it consists of securities (i) if the securities are then traded on a national securities exchange or the NASDAQ Stock Market (or a similar national quotation system), then the value shall be computed based on the average of the closing prices of the securities on such exchange or system over the 30-day period ending three days prior to receipt of such securities by the Company, (ii) if the securities are actively traded over-the-counter, then the value shall be computed based on the average of the closing bid prices over the 30-day period ending three days prior to the receipt of such securities by the Company, and (iii) if there is no active public market, then the value shall be computed based on the fair market value thereof on the date of receipt of such securities by the Company, as determined in good faith by the Board of Directors; (3) insofar as it consists of property other than cash and securities, be computed at the fair market value thereof at the time of such issuance, as determined in good faith by the Board of Directors; and (4) if Additional Shares of Common Stock are issued together with other shares or securities or other assets of the Company for consideration which covers both, be the proportion of such consideration so received for such Additional Shares of Common Stock, computed as provided in clauses (A)(1), (A)(2) and (A)(3) of this Section 7F.4(d)(iv), in each case as determined in good faith by the Board of Directors. (B) OPTIONS AND CONVERTIBLE SECURITIES. The consideration per share received by the Company for Additional Shares of Common Stock deemed to have been issued pursuant to Section 7F.4(d)(ii), relating to Options and Convertible Securities, shall be determined by dividing (1) the total amount, if any, received or receivable by the Company as consideration for the issue of such Options or Convertible Securities, plus the minimum aggregate amount of additional consideration (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such consideration) payable to the Company upon the exercise of such Options or the conversion or exchange of such Convertible Securities, or, in the case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities by (2) the maximum number of shares of Common Stock (as set forth in the instrument relating thereto, without regard to any provision contained therein for a subsequent adjustment of such number) issuable upon the exercise of such Options or the conversion or exchange of such Convertible Securities. (j) ADJUSTMENT TO THE CONVERSION RATE DUE TO STOCK SPLIT, STOCK DIVIDEND OR OTHER SIMILAR EVENT. If, prior to the conversion of all the Series C-V Preferred Stock, the number of outstanding shares of Common Stock is increased by a stock split, stock dividend or other similar event, the Series C-V Conversion Value shall be proportionately reduced, or if the number of outstanding shares of Common Stock is decreased by a combination or reclassification of shares, or other similar event, the Series C-V Conversion Value shall be proportionately increased. (f) ADJUSTMENT DUE TO CONSOLIDATION, MERGER, EXCHANGE OF SHARES, RECAPITALIZATION, REORGANIZATION OR OTHER SIMILAR EVENT. If, prior to the conversion of all the Series C-V Preferred Stock, (i) there shall be any merger, consolidation, exchange of shares, recapitalization, reorganization or other similar event, as a result of which shares of Common Stock of the Company shall be changed into the same or a different number of shares of the same or another class or classes of stock or securities of the Company or another entity, or (ii) there occurs a sale of all or substantially all of the Company's assets that is not deemed to be a liquidation, dissolution or winding up of the Company pursuant to Section 7F.3(c), then the Series C-V Holders thereafter shall have the right to receive upon conversion of the shares of Series C-V Preferred Stock held by them, upon the basis and upon the terms and conditions specified herein and in lieu of the shares of Common Stock immediately theretofore issuable upon conversion, such stock, securities and/or other assets which the Series C-V Holders would have been entitled to receive in such transaction had the Series C-V Preferred Stock been converted immediately prior to such transaction, and in any such case appropriate provisions shall be made with respect to the rights and interests of the Series C-V Holders to the end that the provisions hereof (including, without limitation, provisions for the adjustment of the Series C-V Conversion Value and the Series C-V Conversion Rate shall thereafter be applicable, as nearly as may be practicable in relation to any securities thereafter deliverable upon the exercise hereof. (g) CERTIFICATES AS TO ADJUSTMENTS. Upon each adjustment or readjustment of the Series C-V Conversion Value pursuant to Sections 7F.4(d), (e) and (f) above, and upon the initial issue of Series C-V Preferred Stock, if any adjustment or readjustment would have occurred prior thereto (but after September 8, 2000) pursuant to the terms hereof, the Company at its expense promptly shall compute such adjustment or readjustment in accordance with the terms hereof and prepare and furnish to each holder of Series C-V Preferred Stock a certificate of the Chief Financial Officer of the Company setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Company shall, upon the written request at any time of any holder of Series C-V Preferred Stock, furnish or cause to be furnished to such holder a like certificate setting forth (i) such adjustments and readjustments, (ii) the then effective Series C-V Conversion Value, and (iii) the number of shares of Common Stock and the amount, if any, of other property which at the time would be received upon the conversion of each share of such Series C-V Preferred Stock. (h) NO IMPAIRMENT. The Company will not, by amendment of its Certificate of Incorporation or through any reorganization, transfer of assets, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist in the carrying out of all the provisions of this Section 7F and in the taking of all such action as may be necessary or appropriate to protect the Conversion Rights against impairment. (i) DEFINITIONS. As used in this Section 7F, the following terms shall have the following meanings: "ADDITIONAL SHARES OF COMMON STOCK" shall mean all shares of Common Stock issued (or, pursuant to Section 7F.4(d)(ii), deemed to be issued) by the Company after September 8, 2000, other than shares of Common Stock issued or issuable: (i) upon conversion of shares of Series C-V Preferred Stock; (ii) to officers, directors or employees of, or financial advisors or other consultants to, the Company pursuant to a Plan or Plans or pursuant to any acquisition, financing or other written agreement so long as any such Plan or written agreement has been approved by the Board of Directors (including at least one of the members of the Board of Directors designated by the holders of the Series C-V Preferred Stock while such holders have the right to designate one or more directors); and (iii) as a dividend or distribution on Series C-V Preferred Stock. "AFFILIATE" shall have the meaning given such term in Rule 405 promulgated under the Securities Act. "COMMON STOCK" shall mean the common stock, no par value, of the Company. "CONVERSION RIGHTS" shall mean the rights to convert Series C-V Preferred Stock into Common Stock as provided in this Section 7F. "CONVERTIBLE SECURITIES" shall mean any evidences of indebtedness, shares (other than Common Stock or Series C-V Preferred Stock) or other securities convertible into or exchangeable for Common Stock. "OPTIONS" shall mean rights, options or warrants to subscribe for, purchase or otherwise acquire either Common Stock or Convertible Securities. "ORIGINAL ISSUE DATE" shall mean _____, 200_ [to be the date the Series C-V Preferred Stock is issued]. "ORIGINAL PURCHASE PRICE" shall mean the original purchase price of $2.65 per share for each share of Series C-V Preferred Stock, as such amount shall be adjusted for all stock splits, combinations, consolidations, stock distributions, stock dividends or other recapitalization transactions involving the Series C-V Preferred Stock. "PLAN" shall mean a written stock grant, option plan or purchase plan or other employee stock incentive program. "PREFERRED STOCK" shall mean the preferred stock, par value $.01 per share, of the Company. "SECURITIES ACT" shall mean the Securities Act of 1933, as amended. "SERIES C-V CONVERSION RATE" shall mean the number of shares of Common Stock into which a share of Series C-V Preferred Stock is convertible. "SERIES C-V CONVERSION VALUE" shall have the meaning given such term in Section 7F.4(a). "SERIES C-V PREFERRED STOCK" shall mean those authorized shares of Preferred Stock of the Company designated as "Series C-V Preferred Stock", par value $0.01 per share. 5. OPTIONAL REDEMPTION OF SERIES C-V PREFERRED STOCK. The Company may, at any time after ______, 200_ [Three years from issue date], and from time to time, call for redemption and repurchase of any and all shares of Series C-V Preferred Stock for a purchase price per share equal to the Series C-V Original Issue Price. The Company shall give written notice via certified mail, and any Series C-V Holder shall have the right to convert the shares of Series C-V Preferred Stock held by it at any time prior to the payment date specified in such notice. Any such redemption and repurchase shall be made from funds legally available for such purpose and which are not otherwise restricted. 6. VOTING RIGHTS. The Series C-V Holders shall have no voting power whatsoever except to the extent otherwise expressly provided by the Delaware General Corporation Law, and no Series C-V Holder shall vote or otherwise participate in any proceeding in which actions shall be taken by the Company or the stockholders thereof or be entitled to notification as to any meeting of the stockholders. 7. PROTECTIVE PROVISION. So long as shares of Series C-V Preferred Stock are outstanding, the Company shall not without first obtaining the approval (by vote or written consent, as provided by the Delaware General Corporation Law) of the holders of at least a majority of the then outstanding shares of Series C-V Preferred Stock: (a) alter or change the rights, preferences or privileges of the Series C-V Preferred Stock, including, but not limited to, the creation or authorization of any Senior Securities. (b) increase the size of the authorized number of Series C-V Preferred Stock; or (c) do any act or thing not authorized or contemplated by this Certificate of Incorporation which would result in taxation of the Series C-V Holders under Section 305 of the Internal Revenue Code of 1986, as amended (or any comparable provision of the Internal Revenue Code as hereafter from time to time amended). If the holders of a majority of the then outstanding shares of Series C-V Preferred Stock agree to allow the Company to alter or change the rights, preferences or privileges of the shares of Series C-V Preferred Stock, pursuant to Subsection (a) above, so as to affect adversely the Series C-V Preferred Stock, then the Company will deliver notice of such approved alteration or change to the Series C-V Holders that did not agree to such alteration or change (the "SERIES C-V DISSENTING HOLDERS"), and the Series C-V Dissenting Holders shall thereafter have the right for a period of 30 days to convert pursuant to the terms of this Certificate of Incorporation as they exist prior to such alteration or change or continue to hold their shares of Series C-V Preferred Stock subject to the approved alteration or change of the rights, preferences or privileges of the Series C-V Preferred Stock. 8. STATUS OF CONVERTED STOCK. In the event any shares of Series C-V Preferred Stock shall be converted pursuant to Section 7F.4, the shares so converted shall be canceled, shall return to the status of authorized but unissued preferred stock of no designated series, and shall not be issuable by the Company as Series C-V Preferred Stock. 9. PREFERENCE RIGHTS. Nothing contained herein shall be construed to prevent the Board of Directors of the Company from issuing one or more series of preferred stock with dividend and/or liquidation preferences on parity with or junior to the dividend and liquidation preferences of the Series C-V Preferred Stock. IN WITNESS WHEREOF, this Certificate of Designations have been duly adopted by the Board of Directors of the Company and have been duly executed on behalf of the Company by its Secretary this ____ day of _____, 200_. ON2.COM INC. By: ---------------------------------- Secretary Attestation: - ----------------------------- Name: EXHIBIT B EXHIBIT B-1 THIS WARRANT AND ANY SHARES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE "ACT"), NOR UNDER ANY STATE SECURITIES LAW AND SUCH SECURITIES MAY NOT BE PLEDGED, SOLD, ASSIGNED, HYPOTHECATED, OR OTHERWISE TRANSFERRED UNTIL (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAW OR (2) THE COMPANY RECEIVES AN OPINION OF COUNSEL TO THE COMPANY OR COUNSEL TO THE HOLDER OF SUCH SECURITIES, WHICH COUNSEL AND OPINION ARE REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH SECURITIES MAY BE PLEDGED, SOLD, ASSIGNED, HYPOTHECATED, OR TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS. THE TRANSFER OF THIS WARRANT AND THE SHARES ISSUABLE UPON THE EXERCISE HEREOF ARE RESTRICTED AS DESCRIBED HEREIN. THE SALE, ASSIGNMENT, TRANSFER, PLEDGE AND OTHER DISPOSITION OF THIS WARRANT AND THE SHARES ISSUABLE UPON THE EXERCISE OF THIS WARRANT ARE RESTRICTED BY THE INVESTOR'S RIGHTS AGREEMENT (THE "INVESTOR'S RIGHTS AGREEMENT"), DATED JUNE 7, 2000. A COPY OF THE INVESTORS' RIGHTS AGREEMENT IS ON FILE WITH THE CORPORATE SECRETARY AT THE PRINCIPAL EXECUTIVE OFFICES OF THE COMPANY. A COPY THEREOF MAY BE OBTAINED AT NO COST UPON WRITTEN REQUEST THEREFOR MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE CORPORATE SECRETARY AT THE PRINCIPAL OFFICES OF THE COMPANY. ON2.COM INC. WARRANT TO PURCHASE 462,264 SHARES OF COMMON STOCK, PAR VALUE $0.01 PER SHARE No.W-C_ _______, 200_ THIS CERTIFIES that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, The Travelers Indemnity Company (the "Holder"), is entitled to subscribe for and purchase from On2.com Inc., a Delaware corporation (the "Company"), upon the terms and conditions set forth herein, at any time or from time to time, during the period commencing on the date set forth above and expiring at 5:00 p.m. (New York City time) on ______, 200_ [To be three years from the date of this Warrant] (the "Expiration Date"), Four Hundred Sixty-Two Thousand Two Hundred Sixty-Four (462,264) shares of the Company's Common Stock, par value $0.01 per share (the "Common Stock"), at an exercise price (the "Exercise Price") per share equal to $2.65. As used herein, the term this "Warrant" shall mean and include this Warrant and any Warrant or Warrants hereafter issued as a consequence of the exercise or transfer of this Warrant in whole or in part. As used herein, the term "Holder" shall include any transferee to whom this Warrant has been transferred in accordance with the terms hereof. The number of shares of Common Stock issuable upon exercise of this Warrant (the "Warrant Shares") and the Exercise Price may be adjusted from time to time as hereinafter set forth in Section 6. 1. This Warrant may be exercised until 5:00 p.m. (New York City time) on the Expiration Date, as to the whole or any lesser number of whole Warrant Shares, by transmission by telecopy of the Election to Exercise, followed within three (3) business days by the surrender of this Warrant (with the Election to Exercise attached hereto duly executed) to the Company at its office at 375 Greenwich Street, New York, New York 10013, or at such other place as is designated in writing by the Company, together with a certified or bank cashier's check payable to the order of the Company in an amount equal to the product of the Exercise Price and the number of Warrant Shares for which this Warrant is being exercised (the "Aggregate Exercise Price"). 2. Upon each exercise of the Holder's rights to purchase Warrant Shares, the Holder shall be deemed to be the holder of record of the Warrant Shares issuable upon such exercise, notwithstanding that the transfer books of the Company shall then be closed or certificates representing such Warrant Shares shall not then have been actually delivered to the Holder. Within five (5) business days after each such exercise of this Warrant and receipt by the Company of this Warrant, the Election to Exercise and the Aggregate Exercise Price, the Company shall issue and deliver to the Holder a certificate or certificates for the Warrant Shares issuable upon such exercise, registered in the name of the Holder or its designee. If this Warrant should be exercised in part only, the Company shall, upon surrender of this Warrant for cancellation, execute and deliver a new Warrant evidencing the right of the Holder to purchase the balance of the Warrant Shares (or portions thereof) subject to purchase hereunder. 3. Any Warrants issued upon the transfer or exercise in part of this Warrant shall be numbered and shall be registered in a Warrant register (the "Warrant Register") as they are issued. The Company shall be entitled to treat the registered holder of any Warrant on the Warrant Register as the owner in fact thereof for all purposes and shall not be bound to recognize any equitable or other claim to or interest in such Warrant on the part of any other person, and shall not be liable for any registration of transfer of Warrants which are registered or to be registered in the name of a fiduciary or the nominee of a fiduciary unless made with the actual knowledge of the general counsel of the Company that a fiduciary or nominee is committing a breach of trust in requesting such registration of transfer. In all cases of transfer by an attorney, executor, administrator, guardian, or other legal representative, duly authenticated evidence of his or its authority shall be produced. Upon any registration of transfer, the Company shall deliver a new Warrant or Warrants to the person entitled thereto. This Warrant may be exchanged, at the request of the Holder thereof, for another Warrant, or other Warrants of different denominations, of like tenor and representing in the aggregate the right to purchase a like number of Warrant Shares (or portions thereof), upon surrender to the Company or its duly authorized agent. Notwithstanding anything contained herein to the contrary, the Company shall have no obligation to cause Warrants to be transferred on its books to any person if, in the opinion of counsel to the Company, such transfer does not comply with the provisions of the Act and the rules and regulations thereunder. 4. The Company, until the expiration or termination of this Warrant, shall reserve and keep available out of its authorized and unissued common stock, solely for the purpose of providing for the exercise of the rights to purchase all Warrant Shares granted pursuant to this Warrant and all other Common Stock Warrants, such number of shares of common stock as shall, from time to time, be sufficient therefor. The Company covenants that all shares of stock issuable upon exercise of this Warrant, upon receipt by the Company of the full Exercise Price therefor, shall be validly issued, fully paid, nonassessable, and free of preemptive rights. 5. The issuance of any Warrant, Warrant Shares or other securities upon the exercise of this Warrant, and the delivery of certificates or other instruments representing such Warrant Shares or other securities, except as otherwise required by law, shall be made without charge to the Holder for any tax or other charge in respect of such issuance, other than applicable transfer taxes. Notwithstanding anything contained herein, all applicable transfer taxes shall be borne by the Holder. 6. The number of Warrant Shares and the Exercise Price shall be subject to adjustment from time to time as provided in this Section. 6.1 If, from September 29, 2000 and prior to the Expiration Date, the Company shall pay or make a dividend or other distribution on any class of capital stock of the Company in Common Stock, the number of Warrant Shares shall be increased by multiplying such number of shares by a fraction of which the denominator shall be the number of shares of Common Stock outstanding at the close of business on the day immediately preceding the date of such distribution, and the numerator shall be the sum of (a) such number of shares and (b) the total number of shares constituting such dividend or other distribution, such increase to become effective immediately after the opening of business on the date following such distribution. 6.2 If, from September 29, 2000 and prior to the Expiration Date, the outstanding shares of Common Stock shall be subdivided into a greater number of shares of Common Stock, the number of Warrant Shares at the opening of business on the day following the day upon which such subdivision or combination becomes effective shall be proportionately increased, and, conversely, if outstanding shares of Common Stock shall each be combined into a smaller number of shares of Common Stock, the number of Warrant Shares at the opening of business on the day following the day upon which such combination becomes effective shall be proportionately decreased, such increase or decrease, as the case may be, to become effective immediately after the opening of business on the day following the day upon which such subdivision or combination becomes effective. 6.3 The reclassification of Common Stock into securities (other than Common Stock) and/or cash and/or other consideration shall be deemed to involve a subdivision or combination, as the case may be, of the number of shares of Common Stock outstanding immediately prior to such reclassification into the number or amount of securities and/or cash and/or other consideration outstanding immediately thereafter, and the effective date of such reclassification shall be deemed to be "the day upon which such subdivision becomes effective" or "the day upon which such combination becomes effective," as the case may be, within the meaning of Section 6.1. 6.4 If and whenever from December 8, 2000 and prior to the Expiration Date, the Company issues or sells any Convertible Securities (as defined below) or any shares of Common Stock for a consideration per share less than the Exercise Price in effect immediately prior to the time of such issue or sale, then immediately upon such issue or sale or deemed issue or sale, the Exercise Price shall be reduced to the Exercise Price determined by dividing (A) the sum of (i) the product derived by multiplying the Exercise Price in effect immediately prior to such issue or sale by the number of shares of Common Stock Deemed Outstanding (as defined below) immediately prior to such issue or sale, plus (ii) the consideration, if any, received by the Company upon such issue or sale, by (B) the number of shares of Common Stock Deemed Outstanding immediately after such issue or sale. In such instances, the number of Warrant Shares shall be increased by multiplying such number of shares by a fraction, of which the numerator will be the Exercise Price in effect immediately prior to such issue or sale, and the denominator will be the Exercise Price immediately after such issue or sale. "Common Stock Deemed Outstanding" means, at any given time, the number of shares of Common Stock actually outstanding at such time, plus the number of shares of Common Stock deemed to be outstanding assuming exercise and/or conversion of the Company's Options (as defined below) and Convertible Securities, whether or not such Options or Convertible Securities are actually exercisable at such time. "Options" means any rights, warrants or options sold or granted by the Company to subscribe for or purchase Common Stock or Convertible Securities. "Convertible Securities" means any stock or securities directly or indirectly convertible into or exchangeable for Common Stock. There shall be no adjustment to the number of Warrant Shares with respect to (A) the issuance or sale of shares or options to purchase shares of the Company Common Stock to employees, officers, directors and consultants of the Company and its subsidiaries (as such number of shares is appropriately adjusted for subsequent stock splits, stock combinations, stock dividends and racapitalizations) pursuant to plans or arrangements approved by the Company's Board of Directors; (B) the issue or sale to other entities or the owners thereof for acquisition purposes; (C) to banks or other institutional credit financing sources; and (D) the issuance of Common Stock upon conversion of any shares of any series of the Company's Preferred Stock. 7. Upon receipt of evidence satisfactory to the Company of the loss, theft, destruction, or mutilation of any Warrant (and upon surrender of any Warrant if mutilated), and upon reimbursement of the Company's reasonable incidental expenses and, if reasonably requested, an indemnity reasonably acceptable to the Company, the Company shall execute and deliver to the Holder thereof a new Warrant of like date, tenor, and denomination. 8. The Holder of any Warrant shall not have, solely on account of such status, any rights of a stockholder of the Company, either at law or in equity, or to any notice of meetings of stockholders or of any other proceedings of the Company, except as provided in this Warrant. 9. This Warrant shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to the rules governing the conflicts of laws. 10. The parties hereby irrevocably consent to the jurisdiction of the courts of the State of New York and of any federal court located in such State in connection with any action or proceeding arising out of or relating to this Warrant, any document or instrument delivered pursuant to, in connection with, or simultaneously with this Warrant, or a breach of this Warrant. IN WITNESS WHEREOF, the undersigned has caused this Warrant to be duly executed by its officers thereunto duly authorized as of the date and year set forth below. Dated: ____________, 200_ ON2.COM INC. By: -------------------------------- Name: Title: FORM OF ASSIGNMENT (To be executed by the registered holder if such holder desires to transfer the attached Warrant.) FOR VALUE RECEIVED, ________________________________________ hereby sells, assigns, and transfers unto __________________ a Warrant to purchase __________ shares of Common Stock, par value $0.01 per share, of On2.com Inc. (the "Company"), together with all right, title, and interest therein, and does hereby irrevocably constitute and appoint attorney to transfer such Warrant on the books of the Company, with full power of substitution. Dated: -------------------- Signature ------------------------ Signature Guaranteed: NOTICE The signature on the foregoing Assignment must correspond to the name as written upon the face of this Warrant in every particular, without alteration or enlargement or any change whatsoever. To: On2.com Inc. - ---------------- - ---------------- ELECTION TO EXERCISE The undersigned hereby exercises his or its rights to purchase _______ Warrant Shares covered by the within Warrant and tenders payment herewith [in the amount of $_________] in accordance with the terms thereof, certifies that he owns this Warrant free and clear of any and all claims, liens and/or encumbrances and requests that certificates for such securities be issued in the name of, and delivered to: (Print Name, Address and Social Security or Tax Identification Number) and, if such number of Warrant Shares shall not be all the Warrant Shares covered by the within Warrant, that a new Warrant for the balance of the Warrant Shares covered by the within Warrant be registered in the name of, and delivered to, the undersigned at the address stated below. Dated: Name: -------------------------- ------------------------------ (Print) Address: ---------------------------------------------------------------------- (Signature) EXHIBIT B-2 THIS WARRANT AND ANY SHARES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE "ACT"), NOR UNDER ANY STATE SECURITIES LAW AND SUCH SECURITIES MAY NOT BE PLEDGED, SOLD, ASSIGNED, HYPOTHECATED, OR OTHERWISE TRANSFERRED UNTIL (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAW OR (2) THE COMPANY RECEIVES AN OPINION OF COUNSEL TO THE COMPANY OR COUNSEL TO THE HOLDER OF SUCH SECURITIES, WHICH COUNSEL AND OPINION ARE REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH SECURITIES MAY BE PLEDGED, SOLD, ASSIGNED, HYPOTHECATED, OR TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS. THE TRANSFER OF THIS WARRANT AND THE SHARES ISSUABLE UPON THE EXERCISE HEREOF ARE RESTRICTED AS DESCRIBED HEREIN. THE SALE, ASSIGNMENT, TRANSFER, PLEDGE AND OTHER DISPOSITION OF THIS WARRANT AND THE SHARES ISSUABLE UPON THE EXERCISE OF THIS WARRANT ARE RESTRICTED BY THE INVESTOR'S RIGHTS AGREEMENT (THE "INVESTOR'S RIGHTS AGREEMENT"), DATED JUNE 7, 2000. A COPY OF THE INVESTORS' RIGHTS AGREEMENT IS ON FILE WITH THE CORPORATE SECRETARY AT THE PRINCIPAL EXECUTIVE OFFICES OF THE COMPANY. A COPY THEREOF MAY BE OBTAINED AT NO COST UPON WRITTEN REQUEST THEREFOR MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE CORPORATE SECRETARY AT THE PRINCIPAL OFFICES OF THE COMPANY. ON2.COM INC. WARRANT TO PURCHASE 1,024,920 SHARES OF COMMON STOCK, PAR VALUE $0.01 PER SHARE No.W-C_ _______, 200_ THIS CERTIFIES that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, The Travelers Indemnity Company (the "Holder"), is entitled to subscribe for and purchase from On2.com Inc., a Delaware corporation (the "Company"), upon the terms and conditions set forth herein, at any time or from time to time, during the period commencing on the date set forth above and expiring at 5:00 p.m. (New York City time) on ______, 200_ [To be three years from the date of this Warrant] (the "Expiration Date"), One Million, Twenty-Four Thousand Nine Hundred Twenty (1,024,920) shares of the Company's Common Stock, par value $0.01 per share (the "Common Stock"), at an exercise price (the "Exercise Price") per share equal to $1.14. As used herein, the term this "Warrant" shall mean and include this Warrant and any Warrant or Warrants hereafter issued as a consequence of the exercise or transfer of this Warrant in whole or in part. As used herein, the term "Holder" shall include any transferee to whom this Warrant has been transferred in accordance with the terms hereof. The number of shares of Common Stock issuable upon exercise of this Warrant (the "Warrant Shares") and the Exercise Price may be adjusted from time to time as hereinafter set forth in Section 6. 1. This Warrant may be exercised until 5:00 p.m. (New York City time) on the Expiration Date, as to the whole or any lesser number of whole Warrant Shares, by transmission by telecopy of the Election to Exercise, followed within three (3) business days by the surrender of this Warrant (with the Election to Exercise attached hereto duly executed) to the Company at its office at 375 Greenwich Street, New York, New York 10013, or at such other place as is designated in writing by the Company, together with a certified or bank cashier's check payable to the order of the Company in an amount equal to the product of the Exercise Price and the number of Warrant Shares for which this Warrant is being exercised (the "Aggregate Exercise Price"). 2. Upon each exercise of the Holder's rights to purchase Warrant Shares, the Holder shall be deemed to be the holder of record of the Warrant Shares issuable upon such exercise, notwithstanding that the transfer books of the Company shall then be closed or certificates representing such Warrant Shares shall not then have been actually delivered to the Holder. Within five (5) business days after each such exercise of this Warrant and receipt by the Company of this Warrant, the Election to Exercise and the Aggregate Exercise Price, the Company shall issue and deliver to the Holder a certificate or certificates for the Warrant Shares issuable upon such exercise, registered in the name of the Holder or its designee. If this Warrant should be exercised in part only, the Company shall, upon surrender of this Warrant for cancellation, execute and deliver a new Warrant evidencing the right of the Holder to purchase the balance of the Warrant Shares (or portions thereof) subject to purchase hereunder. 3. Any Warrants issued upon the transfer or exercise in part of this Warrant shall be numbered and shall be registered in a Warrant register (the "Warrant Register") as they are issued. The Company shall be entitled to treat the registered holder of any Warrant on the Warrant Register as the owner in fact thereof for all purposes and shall not be bound to recognize any equitable or other claim to or interest in such Warrant on the part of any other person, and shall not be liable for any registration of transfer of Warrants which are registered or to be registered in the name of a fiduciary or the nominee of a fiduciary unless made with the actual knowledge of the general counsel of the Company that a fiduciary or nominee is committing a breach of trust in requesting such registration of transfer. In all cases of transfer by an attorney, executor, administrator, guardian, or other legal representative, duly authenticated evidence of his or its authority shall be produced. Upon any registration of transfer, the Company shall deliver a new Warrant or Warrants to the person entitled thereto. This Warrant may be exchanged, at the request of the Holder thereof, for another Warrant, or other Warrants of different denominations, of like tenor and representing in the aggregate the right to purchase a like number of Warrant Shares (or portions thereof), upon surrender to the Company or its duly authorized agent. Notwithstanding anything contained herein to the contrary, the Company shall have no obligation to cause Warrants to be transferred on its books to any person if, in the opinion of counsel to the Company, such transfer does not comply with the provisions of the Act and the rules and regulations thereunder. 4. The Company, until the expiration or termination of this Warrant, shall reserve and keep available out of its authorized and unissued common stock, solely for the purpose of providing for the exercise of the rights to purchase all Warrant Shares granted pursuant to this Warrant and all other Common Stock Warrants, such number of shares of common stock as shall, from time to time, be sufficient therefor. The Company covenants that all shares of stock issuable upon exercise of this Warrant, upon receipt by the Company of the full Exercise Price therefor, shall be validly issued, fully paid, nonassessable, and free of preemptive rights. 5. The issuance of any Warrant, Warrant Shares or other securities upon the exercise of this Warrant, and the delivery of certificates or other instruments representing such Warrant Shares or other securities, except as otherwise required by law, shall be made without charge to the Holder for any tax or other charge in respect of such issuance, other than applicable transfer taxes. Notwithstanding anything contained herein, all applicable transfer taxes shall be borne by the Holder. 6. The number of Warrant Shares and the Exercise Price shall be subject to adjustment from time to time as provided in this Section. 6.3 If, from December 8, 2000 and prior to the Expiration Date, the Company shall pay or make a dividend or other distribution on any class of capital stock of the Company in Common Stock, the number of Warrant Shares shall be increased by multiplying such number of shares by a fraction of which the denominator shall be the number of shares of Common Stock outstanding at the close of business on the day immediately preceding the date of such distribution, and the numerator shall be the sum of (a) such number of shares and (b) the total number of shares constituting such dividend or other distribution, such increase to become effective immediately after the opening of business on the date following such distribution. 6.4 If, from December 8, 2000 and prior to the Expiration Date, the outstanding shares of Common Stock shall be subdivided into a greater number of shares of Common Stock, the number of Warrant Shares at the opening of business on the day following the day upon which such subdivision or combination becomes effective shall be proportionately increased, and, conversely, if outstanding shares of Common Stock shall each be combined into a smaller number of shares of Common Stock, the number of Warrant Shares at the opening of business on the day following the day upon which such combination becomes effective shall be proportionately decreased, such increase or decrease, as the case may be, to become effective immediately after the opening of business on the day following the day upon which such subdivision or combination becomes effective. 6.3 The reclassification of Common Stock into securities (other than Common Stock) and/or cash and/or other consideration shall be deemed to involve a subdivision or combination, as the case may be, of the number of shares of Common Stock outstanding immediately prior to such reclassification into the number or amount of securities and/or cash and/or other consideration outstanding immediately thereafter, and the effective date of such reclassification shall be deemed to be "the day upon which such subdivision becomes effective" or "the day upon which such combination becomes effective," as the case may be, within the meaning of Section 6.1. 6.4 If and whenever from December 8, 2000 and prior to the Expiration Date, the Company issues or sells any Convertible Securities (as defined below) or any shares of Common Stock for a consideration per share less than the Exercise Price in effect immediately prior to the time of such issue or sale, then immediately upon such issue or sale or deemed issue or sale, the Exercise Price shall be reduced to the Exercise Price determined by dividing (A) the sum of (i) the product derived by multiplying the Exercise Price in effect immediately prior to such issue or sale by the number of shares of Common Stock Deemed Outstanding (as defined below) immediately prior to such issue or sale, plus (ii) the consideration, if any, received by the Company upon such issue or sale, by (B) the number of shares of Common Stock Deemed Outstanding immediately after such issue or sale. In such instances, the number of Warrant Shares shall be increased by multiplying such number of shares by a fraction, of which the numerator will be the Exercise Price in effect immediately prior to such issue or sale, and the denominator will be the Exercise Price immediately after such issue or sale. "Common Stock Deemed Outstanding" means, at any given time, the number of shares of Common Stock actually outstanding at such time, plus the number of shares of Common Stock deemed to be outstanding assuming exercise and/or conversion of the Company's Options (as defined below) and Convertible Securities, whether or not such Options or Convertible Securities are actually exercisable at such time. "Options" means any rights, warrants or options sold or granted by the Company to subscribe for or purchase Common Stock or Convertible Securities. "Convertible Securities" means any stock or securities directly or indirectly convertible into or exchangeable for Common Stock. There shall be no adjustment to the number of Warrant Shares with respect to (A) the issuance or sale of shares or options to purchase shares of the Company Common Stock to employees, officers, directors and consultants of the Company and its subsidiaries (as such number of shares is appropriately adjusted for subsequent stock splits, stock combinations, stock dividends and racapitalizations) pursuant to plans or arrangements approved by the Company's Board of Directors; (B) the issue or sale to other entities or the owners thereof for acquisition purposes; (C) to banks or other institutional credit financing sources; and (D) the issuance of Common Stock upon conversion of any shares of any series of the Company's Preferred Stock. 7. Upon receipt of evidence satisfactory to the Company of the loss, theft, destruction, or mutilation of any Warrant (and upon surrender of any Warrant if mutilated), and upon reimbursement of the Company's reasonable incidental expenses and, if reasonably requested, an indemnity reasonably acceptable to the Company, the Company shall execute and deliver to the Holder thereof a new Warrant of like date, tenor, and denomination. 8. The Holder of any Warrant shall not have, solely on account of such status, any rights of a stockholder of the Company, either at law or in equity, or to any notice of meetings of stockholders or of any other proceedings of the Company, except as provided in this Warrant. 9. This Warrant shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to the rules governing the conflicts of laws. 10. The parties hereby irrevocably consent to the jurisdiction of the courts of the State of New York and of any federal court located in such State in connection with any action or proceeding arising out of or relating to this Warrant, any document or instrument delivered pursuant to, in connection with, or simultaneously with this Warrant, or a breach of this Warrant. IN WITNESS WHEREOF, the undersigned has caused this Warrant to be duly executed by its officers thereunto duly authorized as of the date and year set forth below. Dated: ____________, 200_ ON2.COM INC. By: -------------------------------- Name: Title: FORM OF ASSIGNMENT (To be executed by the registered holder if such holder desires to transfer the attached Warrant.) FOR VALUE RECEIVED, ________________________________________ hereby sells, assigns, and transfers unto __________________ a Warrant to purchase __________ shares of Common Stock, par value $0.01 per share, of On2.com Inc. (the "Company"), together with all right, title, and interest therein, and does hereby irrevocably constitute and appoint attorney to transfer such Warrant on the books of the Company, with full power of substitution. Dated: -------------------- Signature -------------------------- Signature Guaranteed: NOTICE The signature on the foregoing Assignment must correspond to the name as written upon the face of this Warrant in every particular, without alteration or enlargement or any change whatsoever. To: On2.com Inc. - ---------------- - ---------------- ELECTION TO EXERCISE The undersigned hereby exercises his or its rights to purchase _______ Warrant Shares covered by the within Warrant and tenders payment herewith [in the amount of $_________] in accordance with the terms thereof, certifies that he owns this Warrant free and clear of any and all claims, liens and/or encumbrances and requests that certificates for such securities be issued in the name of, and delivered to: (Print Name, Address and Social Security or Tax Identification Number) and, if such number of Warrant Shares shall not be all the Warrant Shares covered by the within Warrant, that a new Warrant for the balance of the Warrant Shares covered by the within Warrant be registered in the name of, and delivered to, the undersigned at the address stated below. Dated: Name: -------------------------- ------------------------------ (Print) Address: ---------------------------------------------------------------------- (Signature) -----END PRIVACY-ENHANCED MESSAGE-----